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Introduction 
 
 
 
 
 
This paper is going to present the methodology, the literature and the application of Discrete 
Choice Experiments (DCE) in Health Economics.  
In the first chapter we give a definition of DCEs, describing the theoretical principles on 
which these experiments are based, and how to undertake a DCE. We go through each 
methodological step to conduct a discrete choice experiment, studying in deep how to 
conceptualize the choice process, how to correctly define attributes and levels, and how to 
create the experimental design. Moreover we analyze the importance of conducting a pilot test 
for the experiment, and the importance of a careful selection of the sample and the coding 
methods. A central part in this chapter is the description and examination of the main 
econometric models used in DCEs, with their different strengths and weaknesses. The last 
sections of Chapter I aim to present the validity and the interpretation of the results obtained 
from the discrete choice experiments, highlighting the most problematic points in these 
phases. 
Chapter II presents an overview of the literature about discrete choice experiments, with a 
particular focus on Health Economics. This analysis concerns both the DCE application areas, 
and the most used methodological characteristics of these studies, providing statistics and data 
about the majority of the discrete choice experiments conducted in this field. Finally, the 
chapter provides some particularly significant examples of DCEs in health economics, and 
some critiques and limits of this technique, that we have to be aware of before undertaking 
our quantitative analysis. 
In the third chapter we are going to present a research project of the University of Padova, 
which aims to incorporate patients’ preferences in a new algorithm, in order to efficiently 
allocate organs. In particular, we will present the aim, the method and the results of the paper 
“Eliciting Patients' Preferences in Kidney Transplantation: A Discrete Choice Experiment”, 
written by Genie, Nicolò and Pasini (2017).  
7 
 
This study was undertaken analyzing preferences of patients who are waiting for a kidney 
transplantation and represents the start point of our empirical analysis. 
In Chapter IV, indeed, we will make our contribution to this research project, considering data 
and preferences collected by a DCE conducted with patients already transplanted. Under the 
advice of surgeons and nephrologists of the Ospedale di Padova, we selected four attributes of 
the kidneys candidate to be transplanted: Graft Survival, Infectious Risk, Neoplastic Risk and 
Waiting Time requested to receive the organ.  
We compute patients’ willingness to wait (WTW) for a change in the levels of kidney 
transplant attributes, in order to study respondents’ time and risk preferences for kidney 
transplantation in Italy, and search for heterogeneity of tastes. 
To analyze our data, we used a mixed logit model and we found that there is a clear evidence 
of heterogeneity of preferences, which should not be ignored in the organ allocation process.  
So far, the allocation algorithm has accounted for patients’ (medical and personal) observable 
characteristics, such as age and time spent on dialysis, but it has never taken in consideration 
recipients’ intrinsic and unobservable tastes, such as patience, risk aversion, etc.  
We think that accounting for individual preferences in organ allocation can improve patients’ 
satisfaction, and the efficiency of the algorithm matching kidney and recipient. 
On the other hand, it is important to be very careful in the preferences estimation process, 
which is a very delicate and complex exercise, in which several biases could arise, and the 
interpretation of results is often not easy.  
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I. Discrete Choice Experiments  
 
 
 
 
 
1. Definition 
The discrete choice experiments (DCE) method is a preference valuation technique based on 
Lancaster’s economic theory of value1 and random utility theory2 3. DCEs were originally 
developed in marketing research in the early 1970s, but in recent years they have had a 
growing importance for researchers who want to estimate the value of non-marketable 
commodities, most of all in public health-care system and in transport researches. These 
experiments request the construction of a set of alternatives based on a limited number of 
attributes.  
Lancaster’s characteristics theory of demand assumes that goods, services, or type of health 
care provisions can be valued in terms of their constituent characteristics (attributes). 
Presenting two or more alternatives and asking respondents to choose between them, analysts 
obtain an indication of preferences over those alternatives.  
The random utility theory assumes respondents to take their decision in a utility maximizing 
manner and make choices contingent, upon the levels of attributes in DCE scenarios. 
Then, choice data obtained from respondents can be analyzed using micro-econometric in 
order to understand how the average individual’s utility is affected by the changes in the 
levels of each attribute. Individual utility can be divided into two different components: the 
systematic part, that is a function of attributes and their levels, and a random component, that 
is the error term in the regression equation related to unmeasured preference variation. 
We define:  𝑈𝑖𝑞(𝐴) = 𝑣𝑖𝑞(𝐴) + ε𝑖𝑞  
                                                 
1 Lancaster, K. (1966).  
2 
McFadden D. (1974). 
3
 Hanemann, W. (1984).  
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where 𝑈𝑖𝑞(𝐴) is the indirect utility function of individual q for good i with attributes A, 
𝑣𝑖𝑞(𝐴) is the measurable (systematic) component of utility estimated empirically and 
iqrepresents the unobservable factor.  
The subject will choose i over j if: 
(viq+iq)>(vjq+jq) 
or 
(viq-vjq)>(jq-iq). 
The probability for individual q to choose alternative i over j, with the set of attributes A and 
the choice set C, is given by the probability that difference between the measurable 
components of i and q is higher than the error difference: 
P(iq|A,C)=Pi=[(viq-vjq)>(jq-iq)]. 
Assuming that price, or some proxy for that, is included as an attribute in the choice set, 
willingness to pay (WTP) can be indirectly estimated for both changes in individual attributes, 
as well as changes in any combination of attributes. Assuming a linear utility function, then: 
V= 0+nXn+P+
with 0, n,  as parameters of the model to be estimated, where 0 is the constant that reflects 
the individual’s preferences for a commodity over another, when all the attributes remain the 
same; Xn as the levels of the n attributes of the commodity being valued; nXn as the sum of 
all the effect coefficients; P the price level or some proxy for that; the unobservable error 
term. Following from this it is possible to estimate the respondent’s willingness to pay (WTP) 
for a change in the provision of a service or the welfare impact of a change in policy: 
WTP= (nXn
In order to have a deeper and more practical understanding of DCE technique, we are going to 
analyze how to conduct a discrete choice experiment seeing the method, the details and the 
critical points in the construction of these experiments. 
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2. Methodology: undertaking a DCE 
Lancsar and Louviere
4
 published in 2008 an “User’s guide” to discrete choice experiments. 
The authors highlight three interrelated components of conducting a DCE: 
A) the experimental design used to implement the choice survey and generate choice data; 
B) the discrete choice analysis to estimate preferences from the choice data; 
C) the use of the resulting model to derive welfare measures and conduct other polices 
analyses. 
These components are then divided in the fourteen different steps: 
Phase A 
1) Conceptualizing the choice process 
2) Attribute selection 
3) Level selection 
4) Experimental design 
5) Questionnaire design 
6) Piloting 
7) Population/study perspective 
8) Sample and sample size 
9) Data collection 
Phase B: 
10)  Coding of data 
11)  Econometrics analysis 
12)  Validity  
Phase C: 
13)  Interpretation 
14)  Welfare and policy analysis  
In this section we aim to define and analyze in detail the main phases in assessing the quality 
of a DCE. We will discuss and summarize some of the points above in order to better 
understand the entire process of conducting a discrete choice experiment. 
                                                 
4
 Lancsar, E. and Louviere, J. (2008).. 
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2.1 Conceptualizing the Choice Process 
The first phase, necessary to generate choice data, requires consideration of choice contest, 
composition of choice set, framing of instructions and questions, and their incentive 
compatibility in order to encourage respondents to reveal true preferences. The researcher has 
to decide if the choice format is going to include choice between pairs of alternatives, 
multiple options, binary yes/no choices, or if the choice alternatives are going to be generic 
(ex: therapy A, therapy B) or labelled (ex: dialysis, kidney transplantation). It is important to 
point out that, in the case of choice among hypothetical pairs, respondents are forced to 
choose even when both the alternatives result unappealing and neither of these would be 
chosen in practice. The implicit assumption that respondents always choose to consume a 
good/service raises problems of how to interpret the resulting preferences. This issue can be 
avoided allowing respondents to opt out, choose neither option or choose a set status quo 
option. In this last case it is important to understand what opt out option, or status quo option, 
means to respondents, for example, the latter could be seen as a reference point for gains or 
for losses and it can be the same for all the respondents or can vary. Last but not least, it is 
important to investigate how much experience/knowledge respondents have with the 
good/service in analysis, and what background information and education to provide in order 
to make respondents properly familiar with the arguments and aware of all the implications 
involved.  
2.2  Defining Attributes and Levels 
In DCE studies both quantitative (ex: waiting time) and qualitative (ex: provider of care) 
attributes are often defined and used, but they may not include every attribute important for 
every respondent. For this reason, it is important to well identify the salient attributes to the 
majority of respondents in order minimize any possible inference about omitted attributes. 
Another distinction about attributes that has to be taken in consideration is whether they have 
to be generic or alternative specific, in the former case attributes have the same levels for all 
the alternatives, in the latter some attributes or levels (or both) differ across alternatives. In 
DCEs also unavailable alternatives, such as new horizon medications, can be included by 
stretching level ranges as long as alternatives are plausible and possible to apply.  
Special attention has to be put on risk attributes (such as risk of morbidity, mortality, 
infections, rejection of an organ or other risks associated with different health states) because 
it has been shown in psychological literature that individuals have difficulty in interpreting 
12 
 
risk probabilities, viewing events as more likely if they are familiar; hazard as less risky for 
themselves than for other people
5
.  
The number of levels chosen for the analysis is also relevant: for examples two-level 
attributes only allow estimation of a linear effect, which can be a quite important limitation in 
the model because attributes often exhibit non-linear effects. By the way the correct number 
of attributes levels is context specific, a high number is able to provide more information and 
details, on the other hand it increases task complexity and response variability. 
2.3  Creating Experimental Design 
An experimental design is a sample from all possible combinations of attributes levels used to 
define choice alternatives and choice sets, it can be obtained from catalogues, created using 
software, or by hand. This phase is particularly important for the DCE data generation 
process. The design produces the estimation matrix and respondents provide the dependent 
variables (choices) and co-variates such as socio-demographics. We can distinguish between a 
full factorial design or a fractional factorial design. The former is composed by a complete 
census of all attribute level combinations (if there are X attributes and all have Y levels, the 
full factorial is X
Y
), it allows the estimation of all the main effects and the interaction effects 
between attributes, but it is often considered too large to be used in practice. About this last 
consideration Lancsar and Louviere argue that they are more feasible than many researchers 
think. The authors suggest that full factorials can be blocked into different versions which can 
be randomly assigned to respondents. This would provide more design points without 
increasing the number of choice sets for each respondent, on the other hand this strategy can 
complicate the following econometric analysis. 
The fractional factorial design is a sample selected from the full fractional, in a way that 
guarantees to estimate all the effects of interest in the analysis, such as the main effects and 
the most relevant interaction effects. It is usually recommended avoiding small fractional 
designs and, instead, implementing the largest possible design given constraints, such as 
research budgets and task complexity. Also, fractional factorials can be blocked into versions 
with a bit more complex process than that described above for the full factorial. 
Two key points in creating an experimental design are identification and efficiency. 
Identification determines the effects that can be estimated independently, and efficiency refers 
to the precision with which the effects are estimated and how precise parameter estimates are, 
given a sample size. As we said above, many sources suggest to introduce opt out or status 
                                                 
5
 Loyd A. (2001). 
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quo options : they reduce the efficiency of the experimental design but they guarantee a better 
congruency with consumer theory and real preferences of individuals.  
Huber and Zwerina
6
 define other four design desirable criteria: 
i) Orthogonality: attribute levels in choice appear equally often with each level of 
each other attribute. 
ii) Level balance: levels of each attribute appear with the same frequency. 
iii) Minimum overlap of levels for each attribute in each choice. 
iv) Utility balance: options in each choice set have almost the same probability of 
being chosen. 
These criteria have been criticized both by Street and Burges
7
 and Viney et al.
8
 arguing that 
these properties do not guarantee the optimality of the design. On the contrary, some of them, 
for instance utility balance, can even increase the variance of error component, that can 
consequently impact negatively on parameter estimates.  
2.4  Pilot Test 
This phase is needed to test DCE surveys in their different parts, in an attempt to predict an 
appropriate sample size and improve the experiment design. Pilot tests evaluate generation 
method, and respondents understanding of choice context, attributes and levels. Moreover, 
they are important to check task complexity, the length of the survey, timing, costs, 
feasibility, likely response rate, adverse events and statistical variability, in order to avoid 
wasting time and money on an inadequately design project.
9
 
2.5  Sample and coding 
As in any experiment, DCEs sampling requires consideration about population, opportunity 
costs, program founding, inclusion and exclusion criteria, and relevant perspective. The 
optimal sample size has to be chosen to allow a reliable estimation of models, respecting 
research constraints such as budget and time. It varies with the experimental design, since the 
number of observation should change with the number of choice sets, per respondent, and the 
number of respondents in the sample.  
Coding is the first phase for discrete choice analysis and interpretation of results. It can be 
useful to briefly remind that, for qualitative attributes, it is better to use effects coding
10
 or 
                                                 
6
 Huber, J. and Zwerina, K. (1996). 
7
 Street D.J. and Burgess L. (2008). 
8
 Viney, R., Savage, E. and Louviere, J. (2005). 
9
 En.wikipedia.org. (2017). Pilot experiment.   
10
 Bech, M. and Gyrd-Hansen, D. (2005). 
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dummy variables, while mean-centering numerical attributes are used when we want to 
specify non-linear effects for quantitative attributes, such as quadratic or cubic effects. 
2.6  Econometric analysis models 
The form of the estimated indirect utility function is linked with the type of choice modelled 
(binary or multiple choices), the experimental design, the interaction effects and the 
alternatives definitions (generic or labelled). Consequently, choice models depend on 
different assumptions about distribution, properties of errors and on variance-covariance 
matrices. For this reason, there are a great variety of different econometric models, which can 
be applied in DCEs studies. Below we will briefly describe the three models most used in 
recent years, which are considered the most suitable, even for health economics DCE 
analysis. 
Random Effects Probit Model: a regression model where the dependent variable can take only 
two values, and the underlying assumption is that the individual specific effects are 
uncorrelated with the independent variables. The purpose of the regression is to estimate the 
probability that an observation with particular characteristics falls into a specific category.
11
 A 
limitation of probit model is that it cannot utilize any distribution for the random coefficients, 
but only the Normal.  
Multinomial Logit Model: this classification method has the advantage of being able to cater 
more than two response options, they can also allow respondents to “opt-out” from making a 
decision and they are sometimes associated with a better “goodness of fit”. Multinomial logit 
model, also known as multiclass LR or conditional maximum entropy model, predicts the 
probabilities of the different possible outcomes of a categorical (or nominal
12
) dependent 
variable, given a set of independent variables. The main assumptions under this model are that 
data have to be case specific, the dependent variable cannot be perfectly predicted from the 
independent variables for any case, and collinearity is relatively low, otherwise it is difficult 
to differentiate between the impact of several variables. However multinomial logit model 
does not need the assumption of statistical independence between independent variables, but it 
relies on the independence of irrelevant alternatives
13
, which is not always desirable. The 
                                                 
11
 En.wikipedia.org. (2017). Random effects model.   
12
 Categorical or Nominal dependent variable means that it falls into any one of a set of categories which cannot 
be ordered in any meaningful way. 
13
 Independence of irrelative alternatives assumption states that the odds of preferring one class over another do 
not depend on the presence or absence of other "irrelevant" alternatives. 
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growing use of this procedure reflects the increased use of DCEs incorporating more than two 
choices, or two choices plus an opt-out.  
Mixed Logit Model: is a fully general statistical model for examining discrete choices which, 
in recent years, has had a sharp increase in its adoption in DCEs studies. This model 
overcomes the limitations of the standard logit models by allowing for random  taste 
variation, unrestricted substitution patterns and correlation in observed factors over time.
14
 
With an appropriate specification of variables and distribution of random coefficients (mixed 
logit can utilize any distribution), this model is able to approximate, to any degree of 
accuracy, any random utility model
15
. Moreover, it can accommodate the panel nature of DCE 
data by allowing correlation within subjects over repeated choices. It allows for preference 
heterogeneity across individuals by allowing parameters to vary randomly across individuals. 
A limitation of mixed logit approach is that it requires the imposition of assumptions on the 
distribution of the random coefficients for the validity of findings about preference 
heterogeneity. Normal distribution is commonly applied in literature, but it has been argued 
that other distributions, such as bounded distribution
16
, could be more appropriate, or that the 
distribution of parameters may not be of any standard form. Another possible shortcoming 
derives from the fact that mixed logit model has to be based on a set of well-grounded 
hypotheses, supported by theory concerning researchers’ a priori expectations on population’s 
behavior. In spite of that, Louviere and Eagle
17
 argued that most of the current mixed logit 
studies still rely on statistical theory and not on behavioral theory. 
2.7  Validity  
Validity refers to the degree to which evidence and theory support the interpretations of test 
scores, entailed by proposed uses of tests
18
. There are different types of validity tests used in 
economics, here we focus on the most used validation process applied in DCEs: the internal 
validity test. Nevertheless, we will see other examples of validity test in the next chapter 
reviewing the literature of discrete choice experiments in health economics.  
Tests for internal theoretical validity
19
 involve an assessment of whether coefficients appear 
to move in line with a priori expectations and theoretical rules. In the studies it is generally 
reported that this was the case. A more indirect test of theoretical validity is to consider 
                                                 
14
 Train, K. (2009).   
15
  McFadden, D. and Train, K. (2000).   
16
 Train K, Sonnier G. 
17
 Louviere J, Eagle T. (2006). 
18
 American Educational Research Association, American Psychological Association, & National Council on 
Measurement in Education. (1999)   
19
 Heukelom F. (2009). 
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whether results are consistent with intuition, for example in health economics we may expect 
that patients who have experienced an illness value treatment differently from those with no 
experience, even if economic theory has nothing to say about the relationship between value 
and experience.  
It can be also tested whether results conform to the axioms of consumer theory: many 
researchers analyzed “rationality” of choices (often referred to as internal consistency) and 
excluded “irrational” individuals from analyses. In order to test for rationality, dominance 
tests and transitivity tests have been often used in DCEs studies. The former includes a choice 
set where one alternative is clearly superior, in order to check if respondents are able to 
identify and chose it. The latter would imply observing the following choice pattern: if Choice 
A is preferred to Choice B and Choice B is preferred to Choice C, then Choice A has to be 
preferred to Choice C.  
 Lancsar and Louviere
20
 point out several problems in testing rationality in a reliable way. 
Indeed, apparent irrationality may be due to: 
i) Shortcomings in design and implementation of DCEs; 
ii) Respondent learning about their preferences or tasks; 
iii) Irrationality tests not being conclusive; 
iv) Use of fractional factorials, which cannot identify unique decision rules. 
For these reasons we have to be careful deleting these respondents, because it may omit valid 
preferences leading to bias and lower econometrical efficiency. Lancsar and Louviere 
conclude that random utility theory allows for random errors and, therefore, also “irrational” 
responses should be included in the analysis. 
There has been a debate
21
 
22
 
23
also about the relation between adherence to economic axioms 
and complexity of DCE design: literature from psychology affirms that reliance on simple 
decision-making strategies increases with complexity of tasks. 
As we will notice also in next chapters, all these issues make the validation process a very 
delicate phase in constructing a discrete choice experiment. 
2.8  Interpretation, Derivation of Welfare Measure and Other Policy Analysis 
After estimating the preference model, we have to decide how to use it in policy analysis. One 
of the central issues in this process phase is how to set the relative importance of attributes. 
For instance, when choosing diagnostic tests, we have to define if waiting time is relatively 
                                                 
20
 Lancsar, E. and Louviere, J. (2006).   
21
 De Palma , Myers G, papageorgious Y. (1994). 
22
Scott A. (2002).    
23
 Leave, C., Payne, J., Bettman, J. and Johnson, E. (1994).   
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more important than test accuracy to the patient, or, in an organ transplantation, if risk of post-
operation infections is valued more, by the patient, than risk of rejection. In order to decide 
that many studies measure relative impact of attributes by comparing size and significance of 
estimated attribute parameters. The main problem is that this kind of parameters are not easily 
comparable, because they often do not have a common scale of evaluation. There are various 
methods to compare relative attribute impact, here we will just cite the three most used ones, 
which are: 
-Predicted probability analysis; 
-Marginal Rate of Substitution; 
-Welfare Measure to Value Health and Healthcare.
24
 
To conclude this chapter we report below a table by Lancsar and Louvier
3
, it is an useful 
guideline to summarize all the phases to consider in undertaking a Discrete Choice 
Experiment, with the relative significant issues for each part of this process. 
                                                 
24
 Lancsar E, Louviere J, Flynn T. (2007). 
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II. Literature about Discrete Choice Experiments in Health Economics 
 
 
 
 
 
1. DCE application areas and Health Care Sector 
Discrete Choice experiments were applied for the first time in marketing by Louviere and 
Woodworth in 1983
25
, but they found quickly success also in applied economics, particularly 
thanks to studies about transports and environmental economics. Propper
26
 was the first to 
apply a DCE to the health care sector, then there has been a quick increase in the use of DCEs 
in order to elicit preferences for healthcare products and programs, contributing to outcome 
measurement for the use in both cost-benefit and cost-utility analysis.  
One of the main reasons of the success of these experiments in healthcare is that, in this 
sector, the economic issue of limited resources, and unlimited claims on resources, is 
particularly relevant. There are several decisions in health economics which require facing the 
problem of scarcity, combined with the urgency to make choices between competing claims 
on resources (during the evaluation of appropriate forms of healthcare financing, during the 
evaluation of individual pharmaceuticals or about some service delivery).  
Another important reason of the increasing use of DCEs in health economics is that it well 
faces the problem of lack of revealed preferences data in this sector. This is plausibly due to 
the presence of public and private insurances, that means that patients/consumers rarely face 
market prices, and agency relationship between patients and doctors/physicians, which 
implies that consumptions do not depend only on patient preferences. Another cause may be 
the existence of interventions not available in the market, about which market data relating to 
these do not yet exist. The great advantage of DCEs here is that they allow to use stated 
preferences, i.e. what individual say they would do rather than what they are observed to do
27
, 
                                                 
25
 Louviere, J. and Woodworth, G. (1983).   
26
  Propper, C. (1990).  . 
27
 DCEs are not the only stated preference method commonly used in health sector to investigate preferences and 
to value health outcomes; we should also remind standard gamble, time trade-off, person trade-off and 
contingent valuation. [ Jonsson, M. and Alban, A. (1988).] 
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involving generation and analysis of choice data. DCEs are able to mimic existing markets 
and, also, to create hypothetical and inexistent markets. In this way they provide rich data 
sources for economic evaluation and decision making, and allow investigation of questions 
that would be analytically intractable otherwise.  
Governments and other funders are increasingly interested in public and patience preferences 
in order to plan the levels of healthcare provision, value health outcomes, study the expected 
uptake of new polices/products, and improve clinical/policy decision making and adherence 
with clinical/public health programs. DCEs are often applied also to pharmaceuticals, health 
insurance and health technologies fields. They contribute in eliciting preferences and 
quantifying trade-offs for features, describing products and programs in clinical setting, and in 
other contexts such as preferred health insurance packages, health services configurations, 
time preferences, job choices, lifestyle behavior and priority setting frameworks. 
2. Literature Review 
In recent years some systematic literature reviews have been developed in order to analyze 
literature using DCEs in health economic studies. D. Clark, et al. ( 2014)
28
 summarizes DCE 
literature covering three periods: 1990-2000, 2001-2008, 2009-2012.  
We report below some statistics about the implementation of DCE studies in health 
economics in past years in order to analyze their trend and evolution. However, it is important 
to remember that this study has two limitations: it only includes English language studies, and 
it only uses PubMed (a limited database) to source literature. 
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Fig.1 Average number of DCEstudies/year 
28 Fig.2 Country of origin, AUS Australia, CAN 
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In Figure 1 we can see the average number of DCEs per year, published during each of the 
three periods. The number of publication rose from a mean of 3 application/year (1990-2000) 
to an average of 45 per year (2009-2012) with a peak of 74 in 2012. 
Figure 2 summarizes the number of studies conducted from different countries. We notice 
that, in recent years, there has been an increasing trend in applying DCEs, before conducted 
mainly in UK, across both high-middle and low-income countries, which are indicated under 
the category “other”. 
 
Figure 3 and Figure 4 provide information respectively about the number of attributes used in 
DCE studies across the three time periods, and about different attributes domains divided in: 
Money, Time, Risk, Health status (HS), Healthcare (HC), and Other. 
 
Figure 5 indicates the percentage of studies divided on the basis of the number of choice tasks 
posed by DCEs. We can notice that the majority of the analyses use a number of choice tasks 
between 9 and 16. 
Fig.3 Number of attributes 
28 Fig.4 Attributes domains, HC healthcare, HS 
health status 
28 
Fig.5 Number of choice tasks 
28 
Fig.6 Surveys administrations 
28 
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Figure 6 provides information about the different methods of survey administration chosen in 
the analyzed studies. We can notice the presence of a clear trend away from self-completed 
pen/paper questionnaires and, on the other hand, a sharp increase in the use of computers in 
administering DCEs, involving, always more, internet surveys. This is probably due to time 
saving in analyzing data gathered using computers, to the improvements in pc technology, 
and to the increased use of computers and internet by the world population, that see in Web an 
easy way to reach people, collect information and administrate surveys. 
Figure 7 summarizes the use of design 
catalogues, Websites, and Expert Advice to 
design DCE questionnaires, and shows that 
there has not been any particular big change in 
the use of these over the 20 years in analysis.  
Figure 8 describes the econometric estimation 
procedures used and the distributional 
assumptions adopted. In this analysis it is 
important to point out that the econometric 
methods being increasingly used are those able 
to allow respondents to opt-out from 
registering a preference, in order to ensure that 
the choices, that respondents face, are realistic. 
Some important examples of the utility and the 
advantages of this technique can be found in a 
study about colorectal cancer
29
 screening, and 
in a study evaluating two different smoking 
cessation mechanisms
30
. In the figure we can 
see that, as we anticipated in the previous 
chapter, the most used estimation methods in 
absolute terms over the three periods are: 
random effects probit (RE probit), Multinomial 
Logit (MNL), and mixed logit/ random 
parameters logit procedures (MXL/RPL). 
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Fig.7 Design source 
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Fig.8 a Estimation procedures. b Distributional 
assumptions. Distrib. Distributions, LCM latent 
class model, MNL multinomial logit, MXL/RPL 
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28 
24 
 
Figure 9 depicts different validity tests included 
in the analyzed studies. Given that many 
applications have taken place in countries with 
a publicly provided health care system, and 
therefore with a lack of secondary data sets to 
compare real and stated behavior, most analyses 
use tests for internal theoretical validity 
(Theoretic) which, as we saw in the previous 
chapter, are usually limited to checking if signs 
of estimated parameters are consistent with a 
priori expectations.  
Texts of external validity (External) are particularly noteworthy, because stated preferences 
from DCEs can then be compared with revealed preferences. Unfortunately, as we can notice 
from the figure, there is often little scope to conduct this kind of test, because they are hard to 
apply, particularly when DCEs are conducted in the context of state funded health-care 
provision. 
Another kind of tests quite used in these studies is that for non-satiation. This axiom of choice 
theory says that if, for any amount of a good or service, more is preferred to less, then more 
will be preferred to less also at all larger amounts of that good or service. These tests show a 
decreasing trend across years, probably because, recently, they started to be considered weak 
test of validity and they tend to be passed.  
A small percentage of analyses contained transitivity tests (Transitivity). 
Very few studies use a test relating to Sen’s expansion and contraction properties (Sen’s exp. 
and contraction): the application of this test implies that if Choice Set 1 is narrowed/expanded 
to form Choice Set 2, and the alternatives chosen in Choice Set 1 are also in Choice Set 2, 
then no unchosen alternative should be chosen and no chosen alternative should be unchosen. 
Use of a test for internal compensatory decision making was much more frequent. One of the 
underlying assumptions of DCEs is that individual adopt compensatory decision making, i.e. 
they consider all the attributes included in the experiment and, based on the levels of all 
attributes, make a choice. These tests investigate whether individuals always choose 
according to the best levels of a given attribute. 
Fig. 9 Fig.9 Validity checks. Exp. expansion 
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However quantitative analyses are limited in 
identifying decisions strategies employed by 
respondents and qualitative work will prove 
useful in this area. Figure 10 represents the use 
of qualitative methods to enhance DCE 
processes. The use of qualitative methods to 
inform attribute selection (Attrib. selection) 
fluctuates between 2009 and 2012, showing a 
decline in the last period. A drop in the 
implementation of these techniques is 
potentially worrying because, if the selection 
of attributes is not properly grounded in qualitative research, there may be problems of 
triggering omitted variable bias (i.e. appropriate attributes which result omitted) and also 
some inappropriate attributes that are instead specified. On the other hand, a declining trend in 
the use of qualitative methods, to inform attribute selection, would be of little concern if it is 
triggered by the wider use of DCEs, in contexts in which the decision framework is already 
known (for example, if DCEs are conducted alongside clinical trials). 
In contrast, the applications of other qualitative methods show different trends: the method 
used to inform attribute level selection (Level selection) increased over years; the use of a pre-
testing questionnaire (Pretesting) fluctuated over time with an opposite trend with respect to 
that of attribute selection; the use of debriefing choices (Debriefing), to help strengthen 
understanding, started from a 0% in 1990–2000 analyses to increase until a 8 % 2009–2012. 
Table 1: definition, and details of total number of analyses in each category 
28 
Fig. 10 Fig.10 Use of qualitative methods. Attrib. 
attribute 
28 
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Figure 11 shows the percentage of studies per areas of application, as defined in Table 1 
(categories A, B, C, D, E, F, G, H). Although DCEs have originally been introduced into 
health economics primarily in order to value patient experience, there is clear evidence that 
the application of DCEs has broadened 
considerably by 2000–2008, and even more in 
2009-2012
28
. The main noteworthy categories 
are category A and category C: the former 
involves valuing experience factors and it is 
specific to patient respondents. On the other 
hand, the latter deals with trade-off between 
health outcomes and experience factors and 
includes, also, estimations of trade-off for non-
patient groups. 
Finally, in Figure 12, we can observe 
information on trends relating to main outputs 
used in DCEs analyses, which are here divided 
in ‘willingness to pay unit’ outcome measures 
(WTP), ‘per unit of time’ outcome measures 
(Time), ‘per risk unit’ primary outcome (Risk), 
monetary welfare measures (Money), utility 
scores (Utility), odds ratios (Odds), probability 
scores (Prob.), and in the residual category 
Other. This last one reports data only for the 
time interval 2009-2012 and categorizes 49% 
of the analyses.  
The 2001–2008 analysis states that willingness to pay is still a commonly used output from 
DCEs over that period, but the most recent review shows evidence that the proportion of DCE 
studies using either “per WTP unit” or “monetary welfare measure” as their primary outcome 
is decreasing. This could be due to some concerns in relation to the use of DCEs to elicit 
WTP. Moreover, the hypothetical nature of DCEs can interfere with correct estimates of WTP 
because respondents are not bound by the choices they make
31
. Another problem can arise 
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Fig.11 Areas of application. For the definition of 
categories A, B, C, D, E, F, G, H refer to Table 1
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when we estimate the marginal willingness to pay: we commonly assume that marginal utility 
of money is constant and the cost function is continuous and linear, but there are evidences 
that it is not always true
32
.  
In the next section we are going to analyze some relevant examples of discrete choice 
experiments in health economics in order to see how all the phases seen so far are practically 
implemented, and how DCEs are applied to different topics and in different areas.  
3. Some examples of DCEs in Health Economics 
We have seen that the use of DCEs in health economics has found a broad range of 
application in last year. In this part we decided to analyze two examples which can give a 
good insight into DCE utility and research value. The former  paper well describes each phase 
of the experiment and shows a complex and detailed experimental design, useful for a better 
understanding about how DCEs are practically conducted in their parts. The latter gives a 
good insight about the implementation of mixed logit model in discrete choice experiments, 
and lays the foundations of the econometric theory we will use for the quantitative analysis in 
the next chapters. 
3.1  “Gaining pounds by losing pounds: preferences for lifestyle intervention to reduce 
obesity” 
This study
33
 conducts a discrete choice experiment to investigate the population’s preferences 
for alternative lifestyle interventions in order to reduce and prevent obesity. Data have been 
collected through a web-based questionnaire, with 504 UK adults responding. It is known that 
obesity is a global issue which is exponentially increasingly in recent years
34
, if it continues at 
the current trend, more than half of the population in England will be obese in thirty years
35
. 
Being overweight raises the risk of morbidity for several illnesses such as type 2 diabetes, 
high blood pressure, heart attack, heart diseases and some types of cancer (such as colon 
cancer). A body mass index (BMI) between 30 and 35 can reduce life expectancy by an 
average of three years and when it is over 40 this can reduce life expectancy by eight/ten 
years. Conversely, it has been also proved that losing weight among overweight people 
reduces these risks.  
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Obesity has been the cause for about 30.000 deaths per year in the UK, 9.000 of those before 
retirement age. We see that a very high number of overweight people register in weight-loss 
programs, but also that a huge number of those drop out before the program end. This study 
aims to investigate the factors that influence compliance with these programs, and with the 
propensity to take up and maintain healthy lifestyles. The DCE asks respondents to choose 
between different lifestyle intervention programs to reduce their weight in order to identify 
the efficiency of alternative obesity prevention programs.  
Seven attributes have been selected for the experiment: content of the program, weight change 
after two years, short-term goal, reduced risk of developing type 2 diabetes, reduced risk of 
high blood pressure, time per day, and cost per week. The levels settled for each attribute are 
reported in the table below (Table 2).  
 
The DCE questionnaire is generated using SAS software, which minimizes uncertainty 
around parameter estimates and generated an experimental design composed by 72 choice 
sets, to which a “Current lifestyle option” is added in order to make respondents choices more 
realistic. The study gathers information also about personal and socio-economic 
characteristics of respondents: age, height, weight, general health status, whether they smoke. 
Two Sen’s expansion property tests are added in order to check whether respondents are 
engaged in the experiment. Authors include standard rationality tests and compare results with 
and without including “irrational” responses. Two pilots have been conducted by email, the 
first one had three version of the questionnaire, differing for the number of choices included 
 Table 2: Attributes and levels within the discrete choice experiment  
33 
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(40, 22, and 12 choices). Response rate for the three versions was low, therefore a new design 
with 24 choices divided in three blocks was developed, but also this second pilot registered a 
too poor response rate. Finally, a market research company used a web-based online survey to 
collect the final data set giving a financial incentive of £2 for completion. 
Figure 13 shows an example of choice set. 
Authors use a multinomial probit model to implement the econometric analysis estimating the 
equation reported below. They allow for a general covariance structure in error terms to 
address violations of independence of irrelevant alternatives. 
Vij = β0j + β1Content1ij + β2Content2ij + β3Content3ij+ β4Content4ij + β5Content5ij + 
β6Content6ij+ β7Weight0ij + β8Weight 1 2⁄ ij + β9Weight1ij+ β10Weight1 
1
2⁄ ij + 
β11Look betterjt+ β12Feel betterij + β13Look better and feel betterjt+ β14DB 0ij 
+ β15DB Sij + β16DB Mij+ β17DB Lij + β18HP 0ij + β19HP Sij+ β20HP Mij + 
β21HP Lij + β22Time per dayij+ β23Time per day
2
ij + β24Cost per weekiji + εij. 
Where V is the utility from the proposed lifestyle intervention program, and the different 
combinations of the attribute levels are those defined in Table 2. 
Subscript i denotes the individual respondent and j the alternatives within a choice set. β0j is 
the alternative specific constant (ASC). ɛij is the error term, assumed to be normally 
distributed. 
Table 3 and Table 4 show, respectively, the characteristics of respondents, and the probit 
regression results of preferences for lifestyle intervention. We notice that the positive and 
significant constant implies a general preference for current lifestyle. Moreover, we can 
observe that, despite evidences that diets are more effective in order to reduce weight, 
Figure 13: Choice Set Example 
33 
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respondents prefer to change their lifestyle, introducing or increasing physical activity, rather 
than a dietary intervention. Sensitivity to financial costs results significant, conversely, a 
behavior change support is shown to have poor value to respondents. This suggests that 
financial incentives may be used to promote healthy lifestyle interventions: men would 
require a higher compensation, and those of normal weight, who will gain weight over time 
without a proper change in their lifestyles, require the highest incentive. 
 
Table 3: Characteristics of 
31 
 
 
3.2  “Preference heterogeneity and choice of cardiac rehabilitation program: Results 
from a discrete choice experiment” 
This paper
36
 studies Danish patients’ preferences for Cardiac Rehabilitation (CR) activities, 
using a discrete choice experiment. It is based on the assumption that factors influencing 
patients’ utility include characteristics of rehabilitation programs, as well as personal features. 
The DCE considers five possible attributes/activities (physical exercise, personal meetings, 
group counseling meetings, diet guidance, smoking cessation course) with two levels each 
(Yes/No). They are better described in Table 5.  
The experimental design was composed by 32 alternative programs, from those six 
alternatives were removed in order to ensure realism between the choice scenarios and actual 
CR programs, offered by hospitals in Copenhagen Country, and prevent the occurrence of 
                                                 
36
 Kjær, T. and Gyrd-Hansen, D. (2008).   
Table 4: Probit Regression results of preferences for lifestyle interventions
33 
32 
 
dominant and dominated alternatives in the choice sets. Pilot tests have been implemented 
through a series of focus group interviews with cardiac patients from hospitals. Finally, 742 
cardiac patients were asked to choose the preferred rehabilitation program for each of the 
eight choice sets. From those 511 of respondents answered at least one of the choice 
questions, with a satisfactory final response rate of 69%.  
The econometric analysis has been realized using both a standard logit and a mixed logit 
model (reported as RPL: random parameter logit). This last model was chosen in order to test 
for taste heterogeneity in the cardiac activities and, as we have seen in the previous chapter, it 
requires some assumptions:  
• the distribution of randomness in the coefficients was assumed a standard Normal with zero 
mean and variance equal to 1; 
• all five attribute parameters are assumed to be random and normally distributed. 
Moreover, the authors control for some heterogeneity in the mean introducing two interaction 
effects, which account for older people (coded = 1 for the oldest 25% of the sample,>75 years 
old; zero otherwise), and for smokers (coded = 1 for smokers, zero otherwise). 
The results for both the estimation models are reported in Table 6.   
The loglikelihood index (R
2
) for the RPL model is considerably higher than in standard logit 
model, moreover the assumption of preference homogeneity is rejected, indeed the 
explanatory power of the mixed logit is significantly greater than with the logit model. We 
observe also that all five estimated attributes have standard deviations significant and 
relatively large, which confirms a high level of heterogeneity among respondents, even when 
age and smoking status are taken into account. For all these reasons we can conclude that, if 
the assumptions about parameters and distributions in the RPL model are not misleading, this 
model is far more suitable and reliable for this analysis. 
The younger group of patients, on average, values the offer of personal meetings highest, 
followed by physical exercise and diet guidance. 
 On the other hand, patients aged 76 or older tend to value rehabilitation activities less 
attractive, we can see that, in the mixed logit model, all five interactions for elderly patients 
are negative and significant at a 5% level. We observe also that smokers value physical 
exercise and diet guidance less than non-smoking patients. 
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4. Limits and critiques to DCE application in health sector 
We have seen so far, the methodology, the application and the utility of discrete choice 
experiments, but we have not talked about DCE drawbacks. In this section we are going to 
focus on some of the critical points, raised by Bryan and Dolan
37
, about DCE increasing use 
in health economics. The authors identify four specific weaknesses: 
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a) Normative issues, related to how data from DCE studies might be used to inform policy. 
The discussion concerns “whose preferences about what are relevant to which policy”. 
Bryan and Dolan conclude that DCE are more descriptive when applied to private health 
insurance schemes than to predominantly tax-based systems, such us in Italy and in most 
of the European countries. They highlight that many DCEs in health economics are 
conducted with specific patient groups, but they consider also non-health benefits. 
Moreover, they argue that, in order to inform policy decisions, the appropriate context 
would be a tax-based health care system, that would make all tax-payers implicitly be the 
most appropriate study group. 
b) Psychological issues concerning the meaningfulness of the data generated, in particular 
about the effects that the process of elicitation itself have on constructing preferences. 
Moreover, they note that in many cases the very low response rates registered in DCE 
studies may depend on the “choice task” method, which presents some considerable 
cognitive challenges for respondents, who are often requested to process a large amount 
of information and consider too many tradeoffs between all the attributes.  
c) Technical issues about how the data are generated and how robust they are. The authors 
point out as central issue that the number of discrete choices presented to respondents in 
DCE surveys is often too small compared with the total number of scenarios generated 
(usually eight or nine pairwise choices are reported in questionnaires, when the total 
number of possible scenarios range from 250 and 500). This would raise some doubts 
about the validity and the robustness of results obtained with this highly restrictive 
model. Moreover, they critique the approach used in many DCE studies with respondents 
with dominant preferences: these are commonly excluded from the analysis because they 
are not trading between the attributes. Bryan and Dolan claim that DCEs should include 
preferences of all respondents, such that the results of their analyses have relevance for 
policy decisions that affect all stakeholders.  
d) Generalizability issues, i.e. how representative the sample of respondents, who undertake 
the experiment, are of the population that one wishes to generalize. DCEs results would 
be very context specific (factors such as geography and time are often constant in single 
data sources). Moreover, they would require the preference elicitation exercise to be 
repeated for each clinical setting or technology, before being appropriately extended 
outside the population from which they were estimated.  
The authors, finally, conclude that more caution and circumspection towards DCE studies 
should be applied. 
35 
 
Lancsar and Donaldson
38
 argue with the critiques moved by Bryan and Dolan saying that their 
conclusions do not invalidate DCE method per se. The critiques do not concern the theoretical 
or methodological basis of the experiments, but they only challenge the manner in which 
some DCEs have been applied in health economics so far. 
 
However, the authors conclude that DCEs are not without limitations and several issues, 
about DCE approach in general, and health application specifically. 
 Hence, before applying choice experiments, it is needed a deep understanding of the theory, 
of the methods, and of how appropriately interpret the results. 
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III. DCE on Patients’ Preferences in Kidney Transplantation 
 
 
 
 
 
1. Introduction 
In the last years, the University of Padova, has been conducting several studies and research 
projects in order to incorporate patients’ preferences in a new algorithm in order to efficiently 
allocate organs. This research program particularly focuses on kidney transplantations, and 
already led to the realization of the paper “Eliciting Patients' Preferences in Kidney 
Transplantation: A Discrete Choice Experiment”, (Genie, Nicolò and Pasini, 2017)39. In this 
chapter we are going to describe in detail the aim, the method and the results of this study, 
which were undertaken analyzing preferences of patients who are waiting for a kidney 
transplantation. In the following chapter, we will try to make our contribution considering 
data and preferences collected from patients already transplanted. The goal of both these 
papers is to study patients’ time and risk preferences for kidney transplantation in Italy, and 
search for heterogeneity of tastes. We think that accounting for individual preferences in 
organ allocation can improve patients’ satisfaction and the efficiency of algorithm matching 
kidney and recipient. 
2. Background  
Before entering the details of the research project and its results, we have to spend some 
words defining what transplantations, and in particular kidney transplantations, entail and 
how they are ruled and accomplished in Italy. 
2.1 Transplantation 
Organ transplantation is a surgical operation which consists in the substitution of a damaged 
organ, that cannot more fulfill its normal functions, with another one of the same kind that is 
taken from another individual, who is called donor. For the majority of organs, and in case of 
multi-organs transplantations, these are removed from a dead donor, but in the case of kidney 
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or liver transplantations the organs can derived also from living donors (it is possible to live 
normally with only a kidney or with a partial liver because this last has the ability to 
regenerate itself). Often transplantation is the only possible treatment that guarantees the 
patient to continue to live. Organs that have been successfully transplanted include the heart, 
kidneys, liver, lungs, pancreas, intestine, and thymus. Between those, heart, liver and lungs 
transplantations represent lifesaving surgeries, on the contrary, kidney transplantation is a 
valid therapeutic alternative for patients who have to be treated with dialysis otherwise. 
Dialysis is an effective procedure that performs many of the normal duties of the kidneys, like 
filtering waste products from the blood, but it often implies heavy effects on the body and 
requires several weekly sessions of three/four hours each. 
On the other hand, organ transplantation is a very delicate intervention not only because of the 
surgical techniques that requires, which are almost perfectly refined, but also because of the 
ethical and psychological spheres involved.
40
  
In 2016 Italy registered a record in organ transplants and donations, they have been over 400 
more than those in 2015, reaching 3736 operations. This is the highest number observed in the 
country so far, with the highest increment compared with the previous year. 
2.2  Waiting List and Allocation Protocols 
When a potential donor is identified, all the procedures necessary to evaluate the effective 
eligibility are applied. Whether this process shows that the donation is possible, the selection 
of recipients begins and implies the identification of the patient, in the waiting list, who is the 
most suitable to receive that specific organ. 
Waiting lists are a sort of rankings common to all healthcare services, included the most 
complex ones, such as organ transplantations. They are usually perceived by patients as a 
strong criticality in the system. The main reason for the need of waiting lists is an inadequate 
supply compared with the demand of services, or more specifically in this case, of organs. 
The main difference here is that in other healthcare sectors a structural, organizational, 
technological or professional improvement can consistently lower the waiting time. On the 
other hand, for patients who are waiting for an organ, this may not be sufficient, because the 
likely of transplantation is linked manly to the altruism and the solidarity of another person, 
the donor. 
Currently in Italy all people, citizens or foreign, assisted by the Servizio Sanitario Nazionale 
(SSN) can be registered in the waiting list for transplantations. On the basis of national 
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indications, each transplantation center has to evaluate the clinical suitability of the candidates 
who participate in the program. For the adult recipients, the request of registration takes place 
through a unique Regional center, which gathers all the necessary personal, clinical and 
immunological data.
41
 
As guarantee of the organ safety, there are some guidelines which define the levels of risk that 
are acceptable, and settle on the phases and the modalities in the risk evaluation process. More 
specifically the valuation about the donor suitability must depend on the following four 
points
42
: 
• history of the patient; 
• objective examination; 
• instrumental and laboratory examinations; 
• histopathological and/or autopsy examinations. 
It is categorically forbidden organ transplantations from patients affected by: 
• HIV-1 or HIV-2 seropositivity; 
• HBsAg and HDV contemporary seropositivity; 
• Malignant neoplasm in place (except for some specific exceptions); 
• Systemic infections sustained by microorganisms against which there are no viable 
therapeutic options; 
• Prion diseases ascertained.    
In Italy the coordination of donations and transplantations develops on four different levels: a 
local level (Asl and Centri Trapianti), a regional level (Centri Regionali Trapianto), an 
interregional level (Centri Interregionali Trapianto), and a national level (Centro Nazionale 
Trapianto). The definition of the algorithm for organs allocation is assigned to regional or 
interregional levels, the criteria have to be common, transparent and scientifically valid, and 
the algorithm has to be approved by the Centro Nazionale Trapianto.
43
 However, in all the 
regions the main criteria for kidney allocations are: blood group compatibility, histological 
compatibility, age, and time spent in waiting list.
44
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It is important to report that this year, for the first time, there has been a reduction in the 
number of patients in Italian waiting list for kidney and lungs transplantations, in comparison 
with past years. Nevertheless, the lists remain still very long and the average waiting time is 
close to three years
45
.  
This is stimulating physicians to expand criteria of donor suitability (ECD) in order to 
transplant organs even when their characteristic are not optimal. In recent years the donor 
appropriateness criteria included older people, people with comorbidities (such as 
hypertension, diabetes, suboptimal renal functions) and individuals with risky behaviors 
which may potentially increase the risk of infectious disease transmission. It is still argued 
that, in many cases, discarded organs may be successfully transplanted, if the system for 
allocating them efficiently matched the right organ with the most appropriate recipient, in the 
right amount of time. Most allocation protocols are mainly based on the patients’ waiting time 
on dialysis. Recipients are informed about the risk factors of the organ (and respective donor) 
they will receive, and they are requested to sign an informed consent.  
In Veneto organs are allocated by the Interregional Reference Center (CIR) and the North 
Italy Transplant program (NITp), following the national guide lines. The allocation rules and 
criteria are periodically reviewed by CIR-NITp, and shared with regional centers, with 
transplantation centers and with CNT (National Transplantation Center). From a technical 
point of view, kidney allocation criteria are based on decreasing priority levels, the donor 
characteristics taken in consideration in the allocation algorithm are: 
1) Blood group AB0 
2) Type HLA-A, B, DRB1, DQB1 
3) Age 
4) Risk level; 
5) Region that procures the donor 
The receiver characteristics considered for kidneys allocation, instead, are: 
1) Blood group AB0 
2) Type HLA-A, B, DRB1 
3) Transplant Center Region 
4) Age 
5) List waiting time (including dialysis time) 
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6) PRA (Reactive Antibody Panel) and / or previous transplants 
7) Possible presence of specific donor antibodies 
8) Clinical urgency (absolute and relative); 
9) Adherence to national programs provided by guidelines and protocols; 
10) Combined transplant with other organs; 
11) Entry to the PNI (National Hyperimmune Program) program. 
In Northern Italy, the NITK4 algorithm has been defined in August 16th 2016. It is the current 
kidney allocation algorithm  in Lombardia, Friuli-Venezia-Giulia, Liguria, Marche, Provincia 
Autonoma di  Trento, and Veneto.
46
 
The issue here is that the NITK4 algorithm takes in consideration almost only medical 
variables, and patients are rarely able to express their attitude on the kidney they would rather 
to accept. This organ allocation process is kindly automatic with little involvement from the 
candidates. 
2.3 Valuation on quality of kidney transplantations in Italy (2000-2014) 
The Ministero della Saluta provides periodically, through its website, a review of the data and 
the results relative to all the organs transplantations, and a valuation of all the Transplantation 
Centers in Italy
47
. In this section we will report only some statistics related to kidney 
transplantation relative to the period 2000-2014, but it is important to remind also data of 
2015, with 1882 kidney transplantations, which are increased in 2016, reaching 2086 
operations in Italy
48
. 
The upper part of the table “Prospetto Italia” (Descrizione attività) sums up the number of 
kidney transplantations accomplished yearly in Italy between 2000 and 2014. In the red circle 
we can see also the index of waiting list satisfaction, i.e. the ratio between the number of 
realized transplantations and the number of patients on the waiting list at that time. The 
following parts of this table give more information about the national results of kidney 
transplantations, splitting the number of both adult and pediatric cases by categories and 
complexity (Case MIX), and reporting the average percentage of patients and organs survivals 
between 2000 and 2014, and specifically in 2014 (Risultati). 
Moreover, the graph in green shows the average percentages through the years of patient and 
organ survival an year after the operations in Italy. As we can observe in the graphs below, 
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both the results are slightly above the international percentage computed by CTS 
(Collaborative Transplant Study Europe) between 2000 and 2014. 
The pie chart reports a valuation of the level of reintegration into a normal social activity for 
patients after kidney transplant: 92,7% of patients has a job or has the physical and 
psychological conditions to work. On the contrary, just a 2,6% cannot work because of 
diseases and only the 0,1% of patients is still in hospital during the follow-up period after the 
surgery. 
Finally, the last table of this section describes the index of risk and complexity of operations, 
differentiating for donors’ and recipients’ characteristics. Red cells show that the relative 
Centro Trapianti has a higher risk than the national average, or that the cumulative risk of all 
the accomplished transplantations is higher than the national median. The characteristics 
taken in consideration to compute the risk indices are: both donor and recipient age, recipient 
weight, duration of dialysis treatments, ischemia time, diagnosis, complex cases, number of 
mismatch, thromboxanes (TX) precedents, transplant year, time spent in the waiting list, and 
Panel Reactive Antibody (Max PRA).  
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2.4 The contribution and statistics from Centro Trapianti di Padova. 
The Azienda Ospedaliera di Padova is the national leaders in kidney transplantations, 161 
kidney transplantations have been accomplished in 2016, reaching 2050 operations of this 
kind for the Centro Trapianti di Padova. Fifty operations in 2016 have involved living donors, 
placing Padova as the first in Italy. 
Living donors are a resource that can be implemented  in order to cope with organ deficiency. 
The Centro di Padova has adopted state-of-the-art surgical techniques, such as kidney removal 
with laparoscopy, innovative pharmacological and aferhetic therapies to carry out 
transplantation, even in the presence of blood group incompatibilities. Since 2010, more 
sophisticated desensitization methods have been applied allowing for 57 transplants to be 
performed despite AB0 blood donor and recipient incompatibility. While in the past the 
incompatibility of the blood group was considered an absolute contraindication to the 
transplant, these procedures allowed to proceed with transplantation with good results, 
increasing the number of donations. Padua has also become a reference center for teaching, to 
surgeons from all over Italy, laparoscopic technique for nephrectomy in the living donor.
49
 
3. Eliciting preferences of patients in waiting list for kidney transplantation 
As we anticipated, this study is based on the evidence that often patients’ preferences have 
been largely ignored in kidney allocation algorithm. Moreover, kidney transplantations have 
dialysis as effective alternative, against which candidates on the waiting list can balance risks 
and preferences. Hence, depending on personal, social, cultural and economic status, or on 
other unobservable characteristics, recipients may have different preferences for the attributes 
of the kidneys candidate for the transplantation. Some of them could prefer to wait for a 
longer time in order to receive the “optimal kidney”, others would rather to accept as soon as 
possible the organ, even if it has not all the ideal qualities. Preferences, then, may have a key 
role for optimal matching and for the maximization of welfare to the patients, this paper aims 
to investigate with particular attention heterogeneity in those. This study is the first to apply 
DCE to estimate candidates’ time and risk preferences in kidney transplantations through a 
mixed logit model. Moreover, it estimates patients’ Willingness to Wait (WTW) for changes 
in each transplant attribute level.  
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3.1 Attributes selection and experimental design 
Genie, Nicolò and Pasini applied a discrete choice experiment to elicit patients’ preferences at 
Kidney and Pancreas Transplantation Unit of the Department of Surgery and Organ 
Transplantation, University of Padova. 
In consultation with kidney surgeons and nephrologists of the Ospedale di Padova, the authors 
selected four attributes: Waiting Time, Expected Graft Survival, Infectious Risk, Neoplastic 
Risk.  
Waiting time is determined by recipient's characteristics and by the supply of kidneys of a 
certain type, and it is associated with four different levels. 
Expected graft survival depends on the characteristics of the organ itself and on the 
compatibility between recipient and donor. It works like a measure of how long the organ is 
expected to function, but it is subject to a certain degree of uncertainty. In this study, it has 
three possible levels. 
Infectious risk and neoplastic risk can be “Standard” or “Augmented”. Standard risk, which is 
the most frequent one,  includes cases for which the evaluation process did not identify any 
risk factor for transmittable diseases. This case does not exclude at all infectious or neoplastic 
pathologies, which may still be transmitted even if guidelines and good clinical practice are 
followed. Augmented risk describes cases in which the transplanted kidney has an increased 
risk of transmission of infectious and neoplastic diseases. It is usually justified by the urgency 
of a particular clinical status, and it is combined with an appropriate prophylactic therapy. 
Table 7 summarizes the attributes, with the respective definition, and the levels chosen for 
each attribute. 
 
 
Table 7: Attributes, definition and levels 
39 
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A full factorial design, here, would give rise to 48 possible scenarios (2*2*3*4), which can be 
then combined  into 1128 potential choices. Because of the reasons we analyzed above, about 
too long questionnaires and possible cognitive problems, the authors preferred a fractional 
factorial approach generating 16 choice sets. The design was realized with AlgDesign 
Package in R, in order to identify a pseudo-optimal design: dominant alternatives are here 
excluded, choice sets are not repeated, transitivity and monotonicity axioms are utilized in 
order to minimize the number of choice sets for which the answer can be inferred from a 
previous one. In each choice set, patients have been asked to choose between two alternative 
treatments, reported with the generic labels “Treatment A” and “Treatment B”, for kidney 
transplantations, each of those with different characteristics. It is possible to see an example 
of choice set below. We can notice that neither status-quo option (i.e. dialysis treatment) nor 
opt-out options are included. 
 
3.2 Questionnaire, Data and Pilot test 
The questionnaire also includes some demographic, personal and psychological 
characteristics of recipients used to estimate their impact on time and risk preferences of the 
individuals. These are:  
 Education; 
 Composition of the family; 
 Number of son/daughters; 
 Job and career; 
 If the subject receives an invalidity pension; 
 A group of questions describing the psychological status of the patient; 
 A group of questions describing the quality of life perceived by the patient. 
Figure 14: An example of Kidney Transplant Choice: Which treatment would you 
prefer? (put an X below the chosen treatment)
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A pilot test with 16 choice sets has been conducted taking students as subjects, and no fatigue 
effect was found. 
The data of the final experiment have been collected through face-to-face interviews 
conducted by a psychologist appropriately trained to expose the project and explain the 
attributes and the levels, used in the DCE, in order to minimize possible cognitive problems.  
This approach led to obtain a response rate close to 100%. 
The interviews have taken place from April 14, 2005 to February 8, 2017. The sample is the 
entire population of patients on the waiting list of the kidney and pancreas transplantation unit 
in Padova. As we saw above, the Centro Trapianti di Padova is one of the biggest in Italy, and 
it is comparable with other transplant centers in and outside the country.  
A total of 250 patients on the waiting list have been interviewed, out of them, 248 completed 
the discrete choice sets. Data from these 248 candidates are, then, considered in the final 
analysis. 
Analyzing the data , the authors observed that, as shown in Table 8, the average time spent on 
dialysis is more than three years, comparable with the national average of 2.8 years, and the 
average age of patients is about 50 years.  
The authors used  the Kernel density plot for the distributions of the covariates: Figure 15a 
shows a large variation in time spent on dialysis. It is left-skewed with a strong concentration 
between 0.005 and 5 years. Figure 15b represents the variation in age across the candidates, 
the distribution is right-skewed but almost symmetric, and the center is around 50 of age. 
 
 
 
8:
: 
Figure 15: 
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3.3 Estimation method and general results 
As we have seen in the previous DCE, the authors use random utility models to capture 
heterogeneity in patients’ preferences and, as suggested by McFadden and Train (2000), they 
decided to estimate the model with a mixed logit. 
The predictable component of the overall utility that candidate m derives from choosing 
treatment t on choice set s, given unlabeled alternatives is: 
𝑉𝑚𝑠𝑡 = 𝛽1,𝑚𝑇𝑖𝑚𝑒𝑚𝑠𝑡 + 𝛽2,𝑚𝑆𝑢𝑟𝑣𝑖𝑣𝑎𝑙𝑚𝑠𝑡 + 𝛽3,𝑚𝐼𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑢𝑠𝑚𝑠𝑡 + 𝛽4,𝑚𝑁𝑒𝑜𝑝𝑙𝑎𝑠𝑡𝑖𝑐𝑚𝑠𝑡 
where 𝑇𝑖𝑚𝑒 is the waiting time attribute, 𝑆𝑢𝑟𝑣𝑖𝑣𝑎𝑙 refers to the expected graft survival, 
𝐼𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑢𝑠 and 𝑁𝑒𝑜𝑝𝑙𝑎𝑠𝑡𝑖𝑐 are respectively the infectious and the neoplastic binary variable, 
they are equal to 1 if the relative risk is standard, and zero otherwise. 
Moreover the authors use the waiting time attribute to compute an estimate of the 
“willingness to wait” (WTW) of patient m for each other attribute. This index shows the 
relative importance that a patient gives to each attribute in terms of waiting time (in months) 
for kidney transplantations. 
𝑊𝑇𝑊𝑚 = − 
𝛽𝑘,𝑚
𝛽1,𝑚
 
Analyzing the results reported in Column 1 of Table 9 we can notice that patients exhibit a 
substantial amount of heterogeneity in preferences. The coefficients for all the attributes 
analyzed result significant at 1% level and they have the expected signs: patients prefer 
shorter waiting time, longer expected graft survival and standard infectious and neoplastic 
risks over augmented ones.  
Column 3 summarizes the estimates of the mean willingness to wait for each attribute. It is 
shown that, on average, patients are willing to wait about six months for an extra year in the 
expectation of graft survival, 29 months to have a standard infectious risk, and 30 months for 
a standard neoplastic risk. In order to investigate the entire distribution of individuals, the 
authors use the kernel density plot to represent the individual WTW derived from the mixed 
logit model. From Figure 16 we notice that the distributions of individual WTW have 
different shapes for the attributes considered: 
- the distribution of WTW for an extra year of graft survival shows large preference 
heterogeneity, and a concentration at about 5 months. By the way, it has a long right tail, 
meaning that a consistent fraction of patients would wait even longer that the mean. 
- the distributions in Figure 16b and 16c are less concentreted and show an higher 
heterogeneity in patients preferences about standard risk attributes. 
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Table 9: Mixed Logit Models with Normally Distributed Coefficients and WTW Estimates 
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Figure 16: 
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We can conclude that the change in levels of the attributes varies across patients for 
unobserved reasons, this gives space for further analysis in order to identify covariates that 
may drive differences in WTW. 
For this reasons the authors broke down the analysis for differences in the time spent on 
dialysis, and for different age groups. The relevant results are reported in the following 
sections. 
3.4 Further Analyses: Estimation Results and WTW by Time on Dialysis 
Patients with irreversible chronic kidney problems, and without preemptive transplantation, 
need a dialysis therapy while they are waiting for kidney transplantation. 
Currently the kidney allocation algorithm is, mainly, on first-come first-transplanted basis, i.e. 
the available organ is offered to the patient who has spent longer time on the waiting list, 
without considering that there may be patients who are willing to wait longer than others for a 
better quality kidney. Moreover patients who have spent longer time on dialysis have the 
precedence in receiving the organ, even if other patients may obtain greater health benefits 
from transplantation.  
The authors split the sample into two groups in order to identify possible variations in 
patients’ WTW according to how long they are undergoing the dialysis therapy: patients 
above the median, and patients below the median. Table 10 summarizes the results and the 
WTW estimates of the two groups. All the coefficients are significant at the conventional 
levels, and they have the expected signs for both groups. The most interesting finding is that 
there is evidence that patients with relatively longer time on dialysis are willing to wait longer 
than other patients for better quality kidneys, and this difference is statistically significant for 
all the attributes.   
 
Table 10: Mixed Logit Model result- by Time on Dialysis 
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3.5 Further Analysis: Estimation Results and WTW by Age 
The authors investigated also coefficients and WTW for attributes of kidney transplant 
according to recipients’ age, defining three different groups: age 21-45, age 46-56 and 57-76. 
Table 11 summarizes the results obtained with mixed logit models: we can notice that 
coefficients vary among the different age-groups. There is evidence that younger patients are 
willing to wait longer for better levels of the others three attributes than recipients in the last 
quantiles (56+), and the difference in statistically significant, and older patients have shorter 
WTW, for all the attributes, than other subjects. 
 
 
3.6  Conclusion 
The mixed logit results confirm the presence of preferences’ heterogeneity for all the 
attributes considered. Moreover the authors observe significant differences in WTW for the 
changes in levels of kidney transplant attributes according to age and the time spent on 
dialysis: patients who spent longer time on waiting list (and, hence, on dialysis too) are 
willing to wait longer for a better quality kidney than other candidates, and younger patients 
are, on average, willing to wait longer than older candidates. 
The most important achievement of this study is that it recognizes differences in individual 
preferences for kidney allocation and willingness to wait. The results of this paper might be 
used to adjust the organ allocation algorithm in order to improve recipients’ satisfaction and 
general welfare of patients. 
  
Table 11: Mixed Logit Model Result by Age 
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IV. Econometrical analysis: DCE eliciting preferences of patients after 
kidney transplantation 
 
 
 
 
1. Introduction 
In these last sections we are going to deepen the study of the University of Padova about the 
patients’ preferences in kidney transplantations, seen in the previous chapter.  
In Genie, Nicolò, Pasini (2017) respondents were asked to choose between different 
treatments for themselves. Even if the authors control the results for recipients’ individual 
characteristics, it can be argued that the preferences obtained from this DCE may be affected 
by some sources of bias due to recipients’ unobservable personal experiences.  The literature 
suggests that also cognitive distortions, such as optimism
50
 or pessimism
51
 biases, may have 
driven recipients’ choices and preferences. For instance, we know that optimism bias causes a 
person to believe that he/she is at a lesser risk of experiencing a negative event compared to 
others
52
. It usually transcends gender, nationality and age and it is quite a common source of 
bias in health economics: for example, there is evidence that smokers believes that they are 
less likely to contract lung cancer or disease than other smokers
53
. 
In order to investigate patients’ time, survival and risk preferences, and search for 
heterogeneity of tastes,  we conducted a new DCE utilizing an expedient to avoid bias due to 
these cognitive distortions and to recipients’ personal experiences. We conducted a discrete 
choice experiment among patients who already received kidney transplantation, and asked 
them,  not to make their choices for themselves, but to advice  a fictional individual: Antonio, 
a 45 years old patient, waiting for kidney transplantation. The respondents have to take in 
consideration some other personal characteristics of this imaginary patient, in order to 
formulate their advice with a complete set of information: Antonio has been on dialysis since 
two years and a half ago, and waiting for kidney transplantation for one year and a half. He is 
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married and has two children. Antonio obtained a high-school diploma and now he is an 
office-worker. Apart from kidney diseases, Antonio is in good health. 
By the expedient of choosing for another individual, we want to clear results by eventual 
sources of cognitive bias. By fixing the personal characteristics of the same fictional 
individual to all the respondents, we want to investigate the heterogeneity of tastes,  
highlighting intrinsic individual preferences .We think that the organ allocation algorithm 
should account for these individual tastes, in order to improve patients’ satisfaction and the 
efficiency of the set of rules matching kidney and recipient. 
The discrete choice experiment described in the following pages is based on the same 
information, methodology and the background described in Chapter III. 
1. Experimental design and questionnaire 
In this DCE we used the same attributes (Waiting Time, Expected Graft Survival, Infectious 
Risk, Neoplastic Risk) and levels used in Genie, Nicolò, Pasini’s study, and the same 
experimental design
54
: fractional factorial approach composed by the 16 choice sets included 
also in the previous DCE. These are composed by two alternatives each, and labelled with the 
generic names “Treatment A” and “Treatment B”. As in the previous questionnaire, no opt-
out nor status-quo options are included, we know from the literature that not considering these 
options in the choice sets can cause problems in preferences identification. For instance, a 
respondent could be not satisfied by neither Treatment A nor Treatment B in a specific choice 
set and, instead, be willing to wait longer on dialysis in order to receive a better organ. 
Despite of that, in these studies, it has been chosen to include neither of these options in order 
to force respondents to take a decision, even when the choice would require more time. This 
strategy has been implemented, mainly, in order to gather a higher number of data and a more 
complete set of information. 
We remind that the design has been realized with AlgDesign Package in R, which excluded 
dominant alternatives and repetition of choice sets, and took into account transitivity and 
monotonicity axioms in order to minimize the number of choice sets for which the answer can 
be inferred from a previous one.  
Besides the choice sets, the questionnaire, as the one described in the previous chapter, asks 
some demographic, personal and psychological characteristics of respondents: education, 
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composition of the family, number of son/daughters, job and career, if the subject receives an 
invalidity pension, the psychological status of the patient, and the quality of life perceived by 
the patient. The original text of the questionnaire is reported in Appendix C.  
Moreover, from medical records, we could obtain information about gender, age, and date of 
transplantation for each respondents. 
Finally, the questionnaire includes three mathematical questions, in order to check candidates’ 
cognitive and logic abilities. By the way, we consider these measures not very reliable: 
respondents answered the questionnaire at their own place, so we cannot exclude that those 
who scored a high result have received some sort of help in mathematical computation. 
Moreover, it would be a too strong assumption to think that mathematical abilities can be 
approximated with ability to value own preferences. Hence, we found no reasons to exclude 
from our analyses patients’ preferences on the basis of their scores to these sections, even if 
they obtained a low or zero score. 
2. Sample and data collection 
The sample is defined among a selected population of patients who have received kidney 
transplantation at the Kidney and Pancreas Transplantation Unit in Padova in the period from 
1988, date of the first kidney transplantation in this Transplantation Center, to 2015. The 
sample was selected between those who had the periodical medical examination and check-up 
in the period between May 28, 2015 and the end of the same year. The questionnaires have 
been sent by post in the first months of 2015 to patients who had the examination scheduled 
in the period described above. The respondents have been asked to return the completed 
question by hand to their physician at the Kidney and Pancreas Transplantation Unit in 
Padova. 
549 questionnaires have been sent, out of these, 330 came back: 248 entirely or partially 
completed, and 82 not filled in. 196 questionnaires have never been brought back and 23 have 
never been delivered by post. Hence, 248 candidates are considered in the final analysis, with 
a response rate equal to 45,17%. If the candidates answered completely the questionnaire we 
would have 7936 (248*32) observations for patients’ preferences about attributes and levels, 
but, as we said above, some questionnaires are just partially filled in, hence we have been able 
to collect a total of 7780 observations. This is a quite good result for a postal survey without 
incentives, and it can gives us an idea about perception of this topic as something important 
and valuable to the patients.  
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From a very preliminary analysis of the data we can observe that our sample is composed by 
152 male respondents (62%), 93 females (38%) and three patients for who this data was not 
available. Out of male individuals, the mean age is equal to 57 years, and for women this data 
is equal to 51. The mean age of the total sample is equal to 55 years and it varies from 22 to 
80 years old respondents. Table 12 summarizes these information and the relatives standard 
deviations and ranges. 
Moreover, we reported in Figure 17 the Kernel density plot for the distribution of 
respondents’ age. This distribution is almost symmetric, even if slightly right-skewed, and it 
is  centered at around 55 years of age. 
Table 12: Characteristics of the Sample 
Variables: N° Obs. Mean Age SD (Age) Min Age Max Age 
Males 
Females 
152 
93 
57 
51 
11.862 
11.855 
30 
22 
80 
74 
Total 248 55 12.211 22 80 
 
 
3. Estimation method and general results 
In order to make our results coherent and comparable with those obtained by Genie, Nicolò, 
Pasini, and as suggested by DCE literature, we decided to use a mixed logit model to estimate 
our results and to capture heterogeneity in transplanted patients’ preferences. 
We have to remind that, in this study, patients are not asked to decide for themselves, but to 
advise a fictional recipient with fixed characteristics. In this way we should exclude 
heterogeneity due to recipient’s observable characteristics and we should be able to capture 
 
Figure 17: Kernel plot of the distribution of Respondents’ Age 
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unobservable heterogeneity just due to differences in intrinsic preferences of transplanted 
respondents. 
As in the study analyzed in the previous chapter, we defined the predictable component of the 
utility that candidate m derives from choosing treatment t on choice set s, as: 
𝑉𝑚𝑠𝑡 = 𝛽1,𝑚𝑇𝑖𝑚𝑒𝑚𝑠𝑡 + 𝛽2,𝑚𝑆𝑢𝑟𝑣𝑖𝑣𝑎𝑙𝑚𝑠𝑡 + 𝛽3,𝑚𝐼𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑢𝑠𝑚𝑠𝑡 + 𝛽4,𝑚𝑁𝑒𝑜𝑝𝑙𝑎𝑠𝑡𝑖𝑐𝑚𝑠𝑡 
with 𝑇𝑖𝑚𝑒 as the waiting time attribute, which is set as fixed, 𝑆𝑢𝑟𝑣𝑖𝑣𝑎𝑙 as the expected graft 
survival, 𝐼𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑢𝑠 and 𝑁𝑒𝑜𝑝𝑙𝑎𝑠𝑡𝑖𝑐, respectively, as the infectious and the neoplastic 
binary variables, which are equal to 1 if the relative risk is standard and zero if it is 
augmented. The dependent variable is equal to one for the chosen alternative and zero 
otherwise. 
We also computed, as specified in Chapter III, patients’ willingness to wait (in months) for 
each attributes considered in the model, in order to compare these results with those obtained 
by patients still on the waiting lists.  
Table 13 summarizes the results obtained by our regression (M1) and reports the results 
obtained by Genie, Nicolò, Pasini in the grey part of the table (M2) for comparison. We notice 
that also transplanted patients exhibit a substantial amount of heterogeneity in preferences. All 
the coefficients are significant at 1% level and they have the expected signs. As predictable, 
also transplanted patients prefer shorter waiting time, longer expected graft survival, and 
standard infectious and neoplastic risks. Transplanted patients are shown to be willing to wait 
almost 29 months to have a standard infectious risk (such as patients on waiting list), 5 
months for an extra year in the expectation of graft survival (rather than 6 months for patients 
on the waiting list), and 34 months for a standard neoplastic risk (rather than 30 for patients 
on waiting list). By the way, the difference between WTW of transplanted patients and 
patients on waiting list, is not significantly different from 0, at the 95% confidence level. All 
the t-tests between the corresponding WTW give a t-ratio included between -1.96 and 1.96, 
meaning that the null hypothesis is accepted.  
In Figure 18 we reported kernel density plots for the individual WTW for each attribute, 
derived from the mixed logit model. The distribution of WTW for an extra year of graft 
survival shows a concentration at about 4 months, and it has a long right tail, meaning that a 
consistent fraction of patients would wait even longer that the mean. The distributions for risk 
attributes (here such as in Genie, Nicolò, Pasini’s study) are less concentreted and show an 
higher heterogeneity in patients preferences. 
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 (1) (2) (3) (4) (5) (6) 
 Global SD WTW Global SD WTW 
 M1 M1 M1 M2 M2 M2 
Waiting time -0.083***   -0.054***   
 (0.00398)   (0.003)   
Graft survival 0.389*** 0.293*** 4.720*** 0.308*** 0.292*** 5.722*** 
 (0.0339) (0.0303) (0.322) (0.032) (0.0268) (0.469) 
Standard infectious 2.357*** 1.421*** 28.57*** 1.542*** 1.457*** 28.61*** 
 (0.147) (0.108) (1.358) (0.127) (0.105) (2.055) 
Standard neoplastic 2.835*** 1.799*** 34.36*** 1.598*** 1.274*** 29.66*** 
 (0.180) (0.163) (1.787) (0.133) (0.123) (2.090) 
Cons 0.138***   0.171***   
 (0.0487)   (0.0435)   
Observations 7,780 7,780 7,780 7,636  7,636 
Candidates 248  248 248  248 
Loglikelihood -1946.207   -2042.69   
 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1 
M1 is the mixed logit model for transplanted patients, and M2 is the mixed logit model for 
patients on waiting list (Genie, Nicolò, Pasini, 2017) 
 
Table 13: Mixed Logit Model with Normally Distributed Coefficients and WTW Estimates 
Figure18:  Kernel plots of the distribution of individual WTW for the whole population 
(a) WTW for extra year of survival (b) WTW for standard infectious risk 
(c) WTW for standard neoplastic risk 
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4. Further Analyses 
Genie, Nicolò, Pasini found that recipients’ preferences were driven by their age, and by the 
time they spent on dialysis. If the heterogeneity of tastes was driven only by recipients’ 
characteristics, we would have found that all the respondents advise Antonio (the same in the 
entire questionnaire) to “do the same thing”, regardless their own personal characteristics.  
The evidence of heterogeneity, in the mixed logit results, shows us that preferences do not 
depend only on recipients attributes, but they vary across patients for unobserved reasons.  
So far we excluded that the heterogeneity of preferences depends only on recipients’ personal 
attributes, but we cannot exclude that it is, partially or fully, driven by transplanted 
respondents’ characteristics. 
For this reason, we continue our study through further analyses in order to understand if there 
is any covariate that drives differences in transplanted patients’ willingness to wait. In order to 
do that, we broke down the analysis taking in account several different respondents’ 
characteristics. The relevant results, obtained for differences in patients’ age, both at the time 
of the questionnaire and at the time of transplantation, and for differences in patients’ 
education, are reported and described in the following sections.  
We broke down the analysis also for differences in other covariates, such as gender, whether 
respondents have at least one child, time passed from the transplantation date to the 
questionnaire filling, respondents’ quality of life perception as transplanted patients, and 
patients’ psychological status. None of these covariates gave statistically significant results in 
terms of difference in mean WTW between the analyzed groups. We reported summarizing 
tables with these regression results and the relative willingness to wait in Appendix A. 
Table A.1 reports the estimation results and willingness to wait by gender. As anticipated, we 
observe that males and females show almost the same WTW for each attribute, this despite of 
fact that, in literature, there are several evidences of gender disparity in kidney 
transplantation. These differences concern mainly: 
- chances to receive the organ: for instance, women are shown to have a lower chance of 
receiving kidney transplant than men
55
; 
- men’s and women’s preferences: women are less disposed than males to accept transplant 
surgery
56
; 
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- different knowledge about transplantation diagnosis and therapy: women usually have less 
information about these processes
57
; 
 - survival expectation: long-term retrospective studies in renal transplants revealed that male 
recipients undergo a worse survival in comparison to females
58
. 
Table A.2  reports estimation results and WTW differentiating respondents who have at least 
one child, from those with no child. Even here we found no statistically significant difference 
in the WTW, for any attribute, between the two groups. This result was quite predictable, 
indeed “whether a patient has children” is an attribute that in literature is usually significant 
when it concerns the future recipient of the kidney, because of the impact of the 
transplantation benefits on his/her family and dependents
59
. Here this variable does not 
concern the recipient (Antonio), but respondents’ family composition, so there is no reason, 
and no support from the literature, to expect this covariate to give different results in patients’ 
preferences.  
Table A.3 shows the results for attribute coefficients and WTW by time from the 
transplantation. In Genie, Nicolò, Pasini’s study there is evidence of different patients’ 
preferences by time on dialysis, i.e. by how long it has passed since they started the dialysis 
therapy. Here we wanted to understand if there were similar results even for time from the 
transplantation, i.e. if patients who underwent a transplantation longer time ago have different 
preferences from those who have been transplanted more recently. As anticipated, there is no 
statistically significant evidence of an impact of this covariate on patients’ preferences.  
Table A.4 and A.5 summarize estimation results and WTW by respondent’s quality of life 
perception as transplanted patient. The former is obtained by dividing the sample in two 
quantiles, the latter dividing it in three quantiles. Table A.6 reports results and WTW by 
psychological status directly for three quantiles. In literature we found examples that both 
these variables (quality of life perception
60
 and psychological status
61
) have an impact on 
patients’ preferences on medical treatments. Nevertheless, we found no evidence that these 
covariates affect transplanted patients’ preferences in kidney allocation. In order to implement 
these two studies, we created two indexes based on the principal components analysis. We 
used answers to the question set ‘B1’62, in the questionnaire, for quality of life perception as 
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transplanted patients, and answers to question set ‘B3’58 for the analysis by psychological 
status. We reported the details of the indexes construction and all the general descriptions of 
the quantiles in Appendix B. 
The fact that there is no evidence of an impact of psychological covariates on preferences is a 
very positive finding for our analysis. Indeed, whether the results had been driven by 
respondents’ mood, our study would have strongly appeared weakened and less reliable. 
On the other hand, it may be argued that these results can be biased by a self-selection 
problem in the sample. We notice that the majority of respondents provides a positive score 
on both their quality of life perception and psychological status. This evidence may suggest 
that only patients with a good psychological attitude took part in the experiment, while 
patients with depressed behavior did not answer to the questionnaire. 
4.1  Estimation Results and WTW by Age at Questionnaire Date 
We investigated also coefficients and WTW for attributes of kidney transplant according to 
respondents’ age at the time in which they filled in the questionnaire.  
This analysis will highlight whether respondents’ age affects their intrinsic preferences about 
kidney attributes, regardless differences in recipient’s age.  
We split the sample in three quantiles defining three different groups: age 22-48, age 49-62 
and 63-80.  
Table 14 summarizes the results obtained with mixed logit models: we can notice that 
coefficients vary among different age-groups, but with a different trend from that obtained in 
the study about patients on dialysis. In the previous paper we saw evidence that younger 
patients would be willing to wait significantly longer, for better levels of the attributes, than 
recipients in the last quantiles.  
From our model, conversely, we observe that the youngest group has a shorter willingness to 
wait for graft survival and neoplastic risk than the 49-62 age group. By the way, we should 
not to give too much importance to these results, which can be easily explained through 
literature about individual preferences. There are, indeed, many examples of a higher 
impatience of youngest subjects in comparison to middle age ones
63
 
64
 and it is also very 
plausible that the youngest patients found more difficult to put themselves in Antonio’s shoes, 
mainly when it concerns health and medical issues.  
There are, instead, no statistically significantly differences for any average WTW between 49-
62 and 63-80 age groups, nor between 22-48 and 63-80 groups.  
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If in the DCE with patients on waiting list for a transplantation, recipient’s and respondent’s 
roles coexisted, here it has been possible to separate them and to differentiate the results.  
The evidence of no highly significant differences among age-groups for transplanted patients 
strengthens our hypothesis of heterogeneity due to individuals’ intrinsic preferences, and that 
cannot be justified only by differences in respondents’ ages. 
Table 14: Estimation Results and WTW by Age at Questionnaire Time 
 (1) (2) (3) (4) (5) (6) 
 Mean WTW Mean WTW Mean WTW 
 Age22-48 Age22-48 Age49-62 Age49-62 Age63-80 Age63-80 
       
Time -0.0746***  -0.0815***  -0.0976***  
 (0.00629)  (0.00652)  (0.00859)  
Graft survival 0.286*** 3.833*** 0.4375*** 5.369*** 0.473*** 4.843*** 
 (0.0486) (0.515) (0.05933) (0.574) (0.0719) (0.564) 
Standard 
infectious risk 
2.228*** 29.89*** 2.2982*** 28.20*** 2.575*** 26.37*** 
 (0.250) (2.661) (0.2343) (2.183) (0.283) (2.130) 
Standard 
neoplastic risk 
2.189*** 29.37*** 3.0992*** 38.03*** 3.510*** 35.95*** 
 (0.255) (2.734) (0.3117) (3.037) (0.422) (3.559) 
Cons 0.142*  0.103  0.183*  
 (0.0809)  (0.07978)  (0.0965)  
SD       
Survival 0.194***  0.330***  0.357***  
 (0.0456)  (0.05025)  (0.0681)  
Standard 
infectious 
1.518*** 
 
1.380*** 
 
1.472*** 
 
 (0.199)  (0.1727)  (0.207)  
Standard 
neoplastic 
1.354*** 
 
1.7129*** 
 
2.444*** 
 
 (0.228)  (0.262)  (0.408)  
Loglikelihood -663.86557  -713.90462  
-
557.00329 
 
Observations 2,600 2,600 2,822 2,822 2,358 2,358 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
4.2  Estimation Results and WTW by Age at Transplantation Date 
We computed then coefficients and WTW for attributes of kidney transplant by recipients’ 
age, no more at the time of the questionnaire, but at the time in which they underwent the 
kidney transplantation. We are interested in understanding whether this covariate affects 
respondents’ intrinsic preferences about kidney attributes, always regardless differences in 
62 
 
recipient’s age. Table 15 summarizes these results. We divided the sample in three quantiles, 
the first one includes respondents who underwent the kidney transplantation between 19 and 
42 years of age, the second one from 43 to 55 years of age, and the last one from 56 to 74. We 
notice that there is no statistically significant difference in WTW for any attributes among the 
groups, except for standard neoplastic risk for respondents in the second quantile. This group 
would be willing to wait, on average, over 42 months to obtain a kidney with this 
characteristic, which is significantly higher than the same WTW for both other groups at a 
95% confidence level, and different only from the 19-42 age group, at 99% confidence level.  
This only difference in WTW is too weak to confute our hypothesis of individual intrinsic 
preferences, and, for sure, cannot explain alone the high grade of heterogeneity found for all 
the attributes taken in consideration. 
Table 15: Estimation Results and WTW by Age at Transplantation Time 
 (1) (2) (3) (4) (5) (6) 
 
AgeTrans 
19-42 
WTW 
AgeTrans 
43-55 
WTW 
AgeTrans 
56-74 
WTW 
       
Time -0.0725***  -0.0816***  -0.0989***  
 (0.00602)  (0.00716)  (0.00813)  
Graft survival 0.302*** 4.162*** 0.421*** 5.159*** 0.482*** 4.872*** 
 (0.0514) (0.564) (0.0614) (0.593) (0.0685) (0.526) 
Standard 
infectious risk 
2.169*** 29.91*** 2.196*** 26.91*** 2.663*** 26.92*** 
 (0.240) (2.677) (0.251) (2.355) (0.268) (1.965) 
Standard 
neoplastic risk 
2.091*** 28.83*** 3.451*** 42.30*** 3.268*** 33.04*** 
 (0.251) (2.811) (0.337) (3.232) (0.387) (3.175) 
Cons 0.133*  0.109  0.169*  
 (0.0782)  (0.0872)  (0.0909)  
SD       
Graft survival 0.277***  0.302***  0.303***  
 (0.0459)  (0.0577)  (0.0570)  
Standard 
infectious 
1.329***  1.472***  1.637***  
 (0.170)  (0.202)  (0.217)  
Standard 
neoplastic 
1.560***  1.921***  1.965***  
 (0.228)  (0.294)  (0.321)  
Loglikelihood -713.97686  -588.95732  -615.85832  
Observations 2,740 2,740 2,408 2,408 2,568 2,568 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
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4.3  Estimation Results and WTW by Education 
Finally, we split the sample on the basis of respondents’ education level. We defined three 
groups in order to identify possible variation in patients’ WTW according to their education. 
The groups are: “Elementary”, including respondents who attended only primary and/or 
secondary school, “High-School”, for patients who achieved a high-school diploma, and 
“University”, including respondents with at least a graduation degree. 
From the literature we could expect the most educated individuals to have a lower time 
discount rate
65
. There are several evidences that these individuals are often more patient, and 
more willing to invest their time in order to obtain superior outcomes in the future
66
 
67
 
68
 
69
. 
We could, hence, expect to observe higher WTW among these respondents, that would 
suggest Antonio to wait longer in order to be likely to receive a kidney with better levels of 
the attributes. 
Table 16 summarizes the results obtained from this analysis. We notice that the expectations 
from literature are not supported by the evidences: respondents with the lowest level of 
education are those with the highest willingness to wait for Standard Infectious and Standard 
Neoplastic Risk attributes. The WTW for these attributes decrease when the respondents’ 
education level rises. Between the “Elementary” group and the “College” group, the 
differences in WTW for both the risk attributes are statistically significant, so are the 
differences between WTW for Standard Infectious Risk between “Elementary” and “High-
School”, and between WTW for Standard Neoplastic Risk between “High-School” and 
“College”. 
A possible explanation to these results could be found assuming a correlation between 
respondents’ education level and their profession, and a correlation between professions and 
respondents’ WTW. We may assume, indeed, that the most educated patients are also those 
with more responsibilities at work, such as professionals or managers. These workers are 
usually difficult to substitute, hence they have a higher opportunity cost of waiting for the 
kidney transplantation. They may be, indeed, more impatient to be transplanted soon, in order 
to stop the dialysis treatments, which require quite long time, to resume quickly a normal and 
healthy life, and to maintain their economic status quo.  
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On the other hand, if the most educated respondents were actually the least patient ones, we 
should expect significant differences not only between WTW for risk attributes, but for all the 
attributes taken in consideration including Graft Survival, which appears not to vary between 
any of the three groups. Moreover, we found no support from the literature on the assumption 
of a correlation between profession and willingness to wait. Then, we are led to believe that 
there are other causes for these evidences. 
Moreover we could assume a negative relation between education and risk aversion, i.e. less 
educated patients are more risk averse than those with higher study degrees. However, we 
know from the literature that the relation between these characteristics is unclear, and 
disentangling the different directions it may run is difficult. Many, indeed, are also the 
examples that schooling would increase the level of risk aversion
70
. 
The most reasonable explanation, on which also physicians and nephrologists of the Ospedale 
di Padova agree, is that these differences in WTW between groups depend on an 
overestimation of risk, both neoplastic and infectious, by less educated categories. Even 
though physicians explain and describe to patients the differences between “standard” and 
“augmented” risk levels of both the attributes, it seems likely that these information are 
absorbed differently by patients, depending on the education they received.  
Nephrologists state that such high differences between WTW for standard infectious and 
standard neoplastic risks (respectively 35 and 43 months for the “Elementary” group versus 
23 and 24 months for the “College” group) are not justified from a medical point of view. The 
risks categorized as “augmented”, although higher than “standard” ones, are still very low.  
 Augmented infectious risk:  clinical studies reported in literature,  and those conducted in 
Italy, state that infectious risk categorized as augmented, in kidneys ready to be 
transplanted, can be reduced at the minimum terms when proper precautions are taken. 
Indeed, an organ derived from a donor with an active infection is considered suitable to 
be transplanted only if the infection is not too extensive, and if the microorganism, which 
caused it, has been identified and can be treated with a specific antibiotic without 
additional risks.
71
 
 Augmented neoplastic risk: a kidney, ready to be transplanted, is categorized with an 
augmented neoplastic risk if the donor has had a healed neoplasia in the last 10 years, or if the 
donor has an active neoplastic disease affecting other organs, but its transmission risk to the 
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recipient is much lower than the potential benefit that kidney transplantation would have for 
him/her
72
. Indeed a kidney with an augmented neoplastic risk is subjected to several in-depth 
medical analyses, and it is considered suitable to be transplanted only if no neoplasia has been 
found in the organ. 
Table 16: Estimation Results and WTW by Education 
 (1) (2) (3) (4) (5) (6) 
 Mean WTW Mean WTW Mean WTW 
 Elementary Elementary High-school High-school College College 
       
Time -0.0713***  -0.0830***  -0.106***  
 (0.00625)  (0.00597)  (0.0105)  
Graft survival 0.366*** 5.126*** 0.389*** 4.683*** 0.439*** 4.132*** 
 (0.0592) (0.658) (0.0493) (0.468) (0.0754) (0.537) 
Standard 
infectious risk 
2.476*** 34.71*** 2.245*** 27.04*** 2.399*** 22.56*** 
 (0.255) (2.917) (0.219) (2.052) (0.300) (1.840) 
Standard 
neoplastic risk 
3.054*** 42.81*** 2.892*** 34.83*** 2.548*** 23.97*** 
 (0.333) (4.074) (0.260) (2.459) (0.394) (2.869) 
Cons 0.0420  0.155**  0.273**  
 (0.0819)  (0.0726)  (0.114)  
SD       
Graft survival 0.328***  0.280***  0.258***  
 (0.0519)  (0.0413)  (0.0677)  
Standard 
infectious 
1.590***  1.525***  1.007***  
 (0.198)  (0.177)  (0.209)  
Standard 
neoplastic 
2.129***  1.584***  1.609***  
 (0.292)  (0.221)  (0.323  
Loglikelihood -702.9452  -857.52164  -361.667  
Observations 2,898 2,898 3,416 3,416 1,466 1,466 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
The most important implication from these findings is that physicians need to improve the 
information about both infectious and neoplastic risks provided to the patients, with a 
particular attention for the least educated individuals. These subjects show some difficulties in 
assimilating these concepts, their characteristics and the actual differences between levels.  
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A correct perception of risk by patients is a very important issue for physicians and health-
economists. From the literature we know that personal health risk perceptions may be an 
important determinant of specific health-related behaviors
73
, and it is central to provide the 
most complete education about these attributes to any category of patients, in order to train 
them appropriately and to put them in the position to consciously express their true 
preferences
74
. 
5. Conclusions 
This study aims to highlight patients’ time and risk preferences in kidney transplantation 
through a discrete choice experiment conducted with patients already transplanted, and 
compare the results with those obtained by Genie, Nicolò, Pasini, with patients on waiting list 
for the transplant. 
Differently from this last study, in our DCE, respondents are not asked to choose treatments 
for themselves, but to advise a fictional patient, Antonio, with fixed personal characteristics. 
In this way we should be able to avoid problems arising when subjects are asked to choose for 
themselves, such as cognitive bias, and to highlight respondents’ intrinsic preferences, setting 
recipient’s characteristics as fixed. 
As we could expect, these experimental studies show that both the categories of patients, 
transplanted and on waiting list, prefer a kidney transplant with shorter waiting time, longer 
expected graft survival, standard infectious risk, and standard neoplastic risk.  
The mixed logit results suggest evidences of a substantial amount of preference heterogeneity 
for all the attributes considered, which has never been taken in account in the kidney 
allocation algorithm for transplantations. 
We computed, then, WTW for the change in the levels of kidney transplant attributes, and we 
found that these ratios vary differently in the two studies. For patients on waiting list, 
willingness to wait differs according to age and time spent on dialysis. More specifically, 
younger candidates are willing to wait longer than older candidates for better quality kidney, 
such as patients who spent longer time on dialysis: the longer the time spent on dialysis, the 
longer WTW for better quality kidney in terms of an extra year of graft survival, standard 
infectious risk, and standard neoplastic risk. 
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We show that also transplanted patients’ WTW differ according to respondents’ age (both at 
the time they filled in the questionnaire, both at the time they underwent the transplantation), 
but these relations are very weak and cannot explain the high grade of heterogeneity found by 
the mixed logit model.  
Moreover, we found that WTW for infectious and neoplastic risk attributes differ according to 
respondents’ education. Respondents with the lowest level of education are those with the 
highest willingness to wait for these attributes, and these WTW decrease when the 
respondents’ education level rises. This last result suggest that less educated patients 
overestimate infectious and neoplastic risks in a manner that is not justified from a medical 
point of view. Presumably, this is due to some difficulties to these subjects in assimilating 
these concepts, their characteristics, and the actual differences between levels. 
This finding is particularly significant, because it shows that the heterogeneity in transplanted 
patients’ preferences is, partially, due to some problems in the way physicians and surgeons 
inform patients about the risk attributes considered in our study. This is a sign that these 
patients would need a more complete and accurate information about these attributes, in order 
to be able to consciously express their true preferences. 
We can conclude that the majority of our analysis supports the hypothesis of heterogeneity of 
preferences due to individual intrinsic and unobservable tastes, such as patience or risk 
aversion. The kidney allocation algorithm for transplantation takes in account several medical 
and personal characteristics of candidates on waiting list, but it has never taken in account the 
differences in their preferences. This change would be important in order to improve the 
efficiency of the matching, and patients’ satisfaction. 
Nevertheless, we have seen that the preferences estimation is a very delicate process and it 
certainly requires a great attention to all the possible source of bias that could arise 
undertaking a discrete choice experiment.  
First of all, we suggest adjusting and improving the information procedure about risk 
attributes and their levels, with a particular attention to less educated patients, in order to put 
them in the position to consciously express their true preferences. 
  
68 
 
Appendix A 
Further Results 
Table A.1: Estimation Results and WTW by Gender 
 (1) (2) (3) (4) (5) (6) 
 Mean SD WTW Mean SD WTW 
 Female Female Female Male Male Male 
       
Time -0.0858***   -0.0823***   
 (0.00664)   (0.00514)   
Survival 0.367*** 0.171*** 4.277*** 0.410*** 0.373*** 4.982*** 
 (0.0469) (0.0475) (0.406) (0.0483) (0.0415) (0.473) 
Standard 
infectious risk 
2.411*** 1.272*** 28.11*** 2.342*** 1.623*** 28.47*** 
 (0.230) (0.162) (1.927) (0.196) (0.158) (1.853) 
Standard 
neoplastic risk 
2.931*** 1.486*** 34.17*** 2.781*** 1.951*** 33.81*** 
 (0.276) (0.222) (2.485) (0.240) (0.205) (2.415) 
Cons 0.215***   0.105*   
 (0.0793)   (0.0631)   
       
Observations 2,938 2,938 2,938 4,746 4,746 4,746 
Loglikelihood -716.72035   -1197.620   
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
Table A.2: Estimation Results and WTW by Child 
 (1) (2) (3) (4) (5) (6) 
 Mean SD WTW Mean SD WTW 
 No Child No Child No Child With Child With Child With Child 
       
Time -0.0770***   -0.0871***   
 (0.00651)   (0.00513)   
Survival 0.358*** 0.296*** 4.648*** 0.409*** 0.302*** 4.702*** 
 (0.0567) (0.0504) (0.582) (0.0429) (0.0365) (0.386) 
Standard 
infectious risk 
2.396*** 1.756*** 31.10*** 2.328*** 1.315*** 26.73*** 
 (0.263) (0.213) (2.745) (0.174) (0.133) (1.473) 
Standard 
neoplastic risk 
2.827*** 1.753*** 36.69*** 2.926*** 1.843*** 33.61*** 
 (0.305) (0.249) (3.221) (0.230) (0.203) (2.123) 
Cons 0.0968   0.165***   
 (0.0817)   (0.0613)   
Loglikelihood -693.1299   -1245.8408   
Observations 2,798 2,798 2,798 4,982 4,982 4,982 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
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Table A.3: Estimation Results and WTW by Time from the Transplantation 
 (1) (3) (4) (6) (7) (9) 
 Mean WTW Mean WTW Mean WTW 
 0-2 years 0-2 years 3-7 years 3-7 years 8-23 years 8-23 years 
       
Time -0.0882***  -0.0799***  -0.0798***  
 (0.00664)  (0.00715)  (0.00709)  
Graft survival 0.410*** 4.655*** 0.352*** 4.405*** 0.396*** 4.961*** 
 (0.0533) (0.472) (0.0609) (0.608) (0.0629) (0.615) 
Standard 
infectious risk 
2.337*** 26.51*** 2.439*** 30.52*** 2.319*** 29.05*** 
 (0.226) (1.877) (0.266) (2.541) (0.276) (2.732) 
Standard 
neoplastic risk 
2.806*** 31.83*** 2.821*** 35.29*** 3.015*** 37.76*** 
 (0.278) (2.448) (0.332) (3.446) (0.352) (3.661) 
cons 0.203***  0.140  0.0510  
 (0.0780)  (0.0897)  (0.0878)  
Loglikelihood -748.71345  -592.58048  -599.19906  
Observations 2,962 2,962 2,408 2,408 2,410 2,410 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 
 
Table A.4: Estimation Results and WTW by Quality of Life Perception as Transplanted 
Patient (Two Quantiles) 
 (1) (2) (3) (4) (5) (6) 
 Mean SD WTW Mean SD WTW 
 Low Low Low High High High 
       
Time -0.0728***   -0.0933***   
 (0.00514)   (0.00637)   
Graft survival 0.332*** 0.308*** 4.562*** 0.455*** 0.296*** 4.878*** 
 (0.0473) (0.0425) (0.524) (0.0511) (0.0458) (0.412) 
Standard infectious 
risk 
2.119*** 1.408*** 29.10*** 2.639*** 1.545*** 28.29*** 
 (0.194) (0.148) (2.141) (0.231) (0.174) (1.797) 
Standard neoplastic 
risk 
2.510*** 1.876*** 34.46*** 3.205*** 1.634*** 34.36*** 
 (0.249) (0.229) (2.937) (0.269) (0.216) (2.192) 
Cons 0.125*   0.158**   
 (0.0674)   (0.0721)   
Loglikelihood -1000.0909   -913.29456   
Observations 3,902 3,902 3,902 3,750 3,750 3,750 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
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Table A.5: Estimation Results and WTW by Quality of Life Perception as Transplanted 
Patient (Three Quantiles) 
 (1) (2) (3) (4) (5) (6) 
 Mean WTW Mean WTW Mean WTW 
 Low Low Mid Mid High High 
       
Time -0.076***  -0.0802***  -0.092***  
 (0.00636)  (0.00682)  (0.0079)  
Survival 0.339*** 4.443*** 0.377*** 4.697*** 0.453*** 4.938*** 
 (0.0545) (0.568) (0.0616) (0.615) (0.0626) (0.515) 
Standard 
infectious risk 
2.261*** 29.68*** 2.111*** 26.32*** 2.729*** 29.78*** 
 (0.240) (2.487) (0.255) (2.472) (0.286) (2.174) 
Standard 
neoplastic risk 
2.769*** 36.34*** 2.483*** 30.97*** 3.335*** 36.40*** 
 (0.314) (3.504) (0.298) (2.994) (0.335) (2.756) 
Cons 0.143*  0.133  0.142  
 (0.0822)  (0.0834)  (0.0906)  
Loglikelihood -689.9003  -641.98611  -580.22955  
Observations 2,778 2,778 2,456 2,456 2,418 2,418 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 
Table A.6: Estimation Results and WTW by Psychological Status (Three Quantiles) 
 (1) (2) (3) (4) (5) (6) 
 Mean WTW Mean WTW Mean WTW 
 Low Low Mid Mid High High 
       
Time 
-0.0791***  -0.0929***  -
0.0838*** 
 
 (0.00662)  (0.00736)  (0.00781)  
Survival 0.383*** 4.847*** 0.446*** 4.797*** 0.359*** 4.280*** 
 (0.0578) (0.583) (0.0564) (0.452) (0.0696) (0.671) 
Standard 
infectious risk 
2.165*** 27.37*** 2.665*** 28.69*** 2.465*** 29.40*** 
 (0.231) (2.176) (0.268) (2.139) (0.299) (2.728) 
Standard 
neoplastic risk 
2.813*** 35.57*** 3.210*** 34.55*** 2.617*** 31.21*** 
 (0.296) (3.023) (0.332) (2.741) (0.337) (3.430) 
Cons 0.169**  0.140*  0.120  
 (0.0826)  (0.0840)  (0.0942)  
Loglikelihood -658.30603  -671.71322  -558.7945  
Observations 2,566 2,566 2,788 2,788 2,268 2,268 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
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Appendix B 
Construction of indexes for Quality of Life Perception and Psychological Status 
 
 
1) Quality of Life Perception Index (QLPI) 
 Question Set B1 in the Questionnaire 
In your opinion how true or false are the following sentences? 
 
Principal Components Analysis 
Table B.1: Principal Components Analysis for QLPI computed with Stata.14 
Variables Component 1 Component 2 Component 3 Component 4 Unexplained 
B1.a 0.5451 -0.3533 -0.1391 -0.7475 0 
B1.b 0.4844 -0.5895 0.2897 0.5779 0 
B1.c 0.5112 0.3896 -0.6969 0.3183 0 
B1.d 0.4549 0.6132 0.6412 -0.0773 0 
 
Index Construction and Characteristics 
QLPI = B1.a*(0.5451)
2
+B1.b*(0.4844 )
2
+B1.c*(0.5112)
2
+B1.d*(0.4549)
2
 
with B1.a, B1.b, B1.c, B1.d equals to the number [1-5] expressed by each patient in the 
corresponding section of question set B1. 
B1 
Absolutely 
true  
Generally 
true 
I do not 
know 
Generally 
false 
Absolutely 
false 
a 
 The transplantation 
affected my life too 
much  
1 2 3 4 5 
b 
 The daily cares after 
the transplantation 
(therapies, medical 
check etc.) require too 
much time  
1 2 3 4 5 
c 
 Living as transplanted 
patient is frustrating  
1 2 3 4 5 
d 
 I feel like a burden to 
my family 
1 2 3 4 5 
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The index can vary from a minimum of 1 (for respondents with a bad quality of life 
perception) to a maximum of 5 (when respondents assign the highest score of satisfaction, 5, 
to all the section of question set B1). 
 
Description of the Sample 
Two Quantiles Observations Mean Std. Dev. Min Max 
Below the mean 3,902 3.897 0.629 1,766 4.496 
Above the mean 3,750 4.895 0.147 4.504 5.000 
 
Three Quantiles Observations Mean Std. Dev. Min Max 
1
st
 Quantile 2,778 3.667 0.610 1.766 4.261 
2
nd
 Quantile 2,456 4.597 0.135 4.793 4.766 
3
rd
 Quantile 2,418 4.997 0.024 4.793 5.000 
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2) Psychological Status Index (PSI) 
Question Set B3 in the Questionnaire 
How often, in the last 4 weeks, have you felt… 
B3 Always 
Almost 
always 
Usually Sometimes 
Almost 
never 
Never 
a calm and quiet? 1 2 3 4 5 6 
b full of energies? 1 2 3 4 5 6 
c 
downhearted 
and sad? 
1 2 3 4 5 6 
 
Principal Components Analysis 
Table B.2: Principal Components Analysis for PSI computed with Stata.14 
Variables Component 1 Component 2 Component 3 Unexplained 
B3.a 0.6064 -0.282 0.7435 0 
B3.b 0.5322 0.8386 -0.1160 0 
B3.c -0.5908 0.4661 0.6586 0 
 
Index Construction and Characteristics 
PSI = B3.a*(0.6064)
2
+B3.b*(0.5322)
2
 - B3.c*(-0.5908)
2
 
with B3.a, B3.b, B3.c equals to the number [1-6] expressed by each patient in the 
corresponding section of question set B3. 
Differently from the previous index, here we have to notice that the scores related to answers 
for sections (a) and (b) have different trends from that of section (c): if in the former case the 
lowest score, equal to 1, corresponds to the best psychological status, in questions (c) this one 
corresponds to the worst mood.  
In order to face this problematic we set a negative sign for the component B3.c in the formula. 
For the reasons seen above we can conclude that the index can vary from a minimum of -
1.443 (for respondents with the most positive psychological status) to a maximum of 3.996 
(for respondents with the bluest mood). 
Description of the Sample 
 Observations Mean Std. Dev. Min Max 
1
st
 Quantile 2,566 -0.707 0.264 -1.443 -0.424 
2
nd
 Quantile 2,788 0.089 0.246 -0.359 0.491 
3
rd
 Quantile 2,268 1.208 0.543 0.509 3.189 
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Appendix C 
Original Questionnaire as administrated to transplanted patients 
QUESTIONARIO 
Buongiorno,  
Faccio parte di un gruppo di ricercatori dell’Università di Padova e dell’Università Ca’ 
Foscari di Venezia, che sta svolgendo uno studio che ha lo scopo di valutare se sia possibile 
aumentare il benessere dei pazienti che necessitano di un trapianto di rene.  
Lei è già stato intervistato nell’abito di questo progetto di ricerca, stiamo ora intervistando 
nuovamente tutti i pazienti del centro trapianti di rene e pancreas di Padova.  
La Sua partecipazione a questa indagine è di estrema importanza ai fini della ricerca 
scientifica. Le chiederemo alcune informazioni demografiche, alcune informazioni relative al 
Suo stato di salute generale e infine le chiederemo di esprimere la Sua preferenza circa 
opzioni alternative di trattamenti medici.  
I risultati di questo studio verranno pubblicati in riviste scientifiche specializzate e presentati 
in conferenze scientifiche, ma nessuna pubblicazione o presentazione conterrà mai il Suo 
nome né alcuna informazione che potrebbe identificarLa. Le preferenze da Lei espresse in 
questo questionario non avranno alcuna implicazione sulla allocazione degli organi nel Suo o 
in nessun altro caso, e non verranno incluse nella Sua cartella clinica.  
Tutti i dati raccolti saranno archiviati e analizzati in maniera rigorosamente anonima, ai sensi 
dell’art. 7 e dell’art. 13 del DLgs n. 196/03 in vigore dal 1° gennaio 2004 sulla tutela delle 
persone rispetto al trattamento dei dati personali. È inoltre severamente vietato l’uso dei suoi 
dati a fini commerciali.  
Se non ha domande o richieste di chiarimenti ulteriori, possiamo iniziare l’intervista. 
  
Dati Socio-anagrafici  
D2) Come è composta la sua famiglia (non solo le persone che vivono con lei)? 
 
 
- n°___ - n°_____________ 
 
 
 
- n°_ - n°_____________ 
_____________________________________________________________________  
 
D3) Qual è attualmente la sua professione?  
      
 
 
 
D4) Attualmente gode di una pensione di invalidità ? 
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Benessere psicologico e qualità della vita  
 
B1) Secondo lei quanto vere o quanto false sono le seguenti affermazioni? 
 
assolutamente 
vera 
in genere 
vera 
non so 
in genere 
falsa 
assolutamente 
falsa 
a 
La vita da trapiantato mi 
condiziona troppo 
1 2 3 4 5 
b 
La gestione quotidiana del 
trapianto (terapie, controlli 
ecc.) mi fa perdere troppo 
tempo 
1 2 3 4 5 
c 
Trovo frustrante vivere da 
trapiantato 
1 2 3 4 5 
d 
Mi sento un peso per la mia 
famiglia 
1 2 3 4 5 
 
B2) In generale direbbe che la sua salute è? 
 Ottima Molto buona Buona Discreta Scadente 
A 1 2 3 4 5 
  
B3) Per quanto tempo nelle ultime 4 settimane si è sentito…  
 Sempre 
Quasi 
sempre 
Molto 
tempo 
Una parte 
del tempo 
Quasi 
mai 
Mai 
a 
Calmo e 
sereno? 
1 2 3 4 5 6 
b 
Pieno di 
energie? 
1 2 3 4 5 6 
c 
Scoraggiato e 
triste? 
1 2 3 4 5 6 
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Preferenze dei pazienti  
In questa sezione le saranno presentate sedici opzioni alternative di trattamenti. La sarà 
chiesto di esprimere la sua preferenza tra il trattamento A e il trattamento B ponendo una X 
nel riquadro sotto di esse. Le ricordiamo di nuovo che le risposte non avranno alcuna 
influenza sulle terapie che le verranno proposte.  
•     la sopravvivenza dell'organo trapiantato è determinata dalle caratteristiche dell'organo 
stesso, dalle caratteristiche del ricevente e dalla compatibilità tra donatore e ricevente. 
Queste caratteristiche permettono di stimare per quanto tempo l’organo trapiantato sarà 
funzionante. Tale valutazione è il risultato di un calcolo probabilistico basato su dati 
clinici precedenti e sull’esperienza del medico che esegue la valutazione, ma come tale 
è soggetta ad un certo grado di incertezza.  
•      il rischio infettivo (standard o aumentato) è il rischio di contrarre una malattia infettiva 
attraverso l'organo trapiantato. Se è standard, l'organo trapiantato è stato sottoposto a 
tutti i controlli necessari, anche se non è possibile escludere del tutto tale rischio. Se il 
rischio è aumentato, l'organo trapiantato è stato sottoposto a tutti i controlli necessari, 
ma il donatore aveva tenuto dei comportamenti a rischio nei giorni precedenti al suo 
decesso ed un’eventuale infezione potrebbe non essere rilevabile anche dai più accurati 
controlli;  
•    il rischio neoplastico (standard o aumentato) è il rischio di contrarre una neoplasia 
attraverso l’organo trapiantato. Se è standard, il donatore non era affetto da neoplasie 
rilevabili clinicamente, anche se non è possibile escludere del tutto tale rischio. È 
aumentato nel caso il donatore sia stato affetto in passato da patologie neoplastiche che 
sono state curate e considerate guarite o da neoplasie senza potenziale di diffusione ad 
altri organi. Il rischio di trasmissione dal donatore al ricevente è comunque minimo.  
•     il tempo d'attesa è il numero di mesi che si dovranno aspettare per ottenere il trapianto 
proposto. Il tempo d’attesa dipende dalle caratteristiche del ricevente e dalla frequenza 
con cui sono solitamente disponibili donatori di una certa tipologia. Queste 
caratteristiche permettono di valutare approssimativamente il tempo d’attesa, anche se 
c’è sempre una qualche probabilità che l’attesa sia inferiore o superiore a quanto 
dichiarato.  
 
 
 Antonio è un paziente in attesa di trapianto di rene. Antonio ha 45 anni, è in dialisi da due 
anni e mezzo, è in attesa di un trapianto di rene da un anno e mezzo, è sposato ed ha due figli. 
Antonio ha un titolo di scuola superiore ed è impiegato. A parte i problemi ai reni, Antonio 
gode di buona salute. 
Antonio deve esprimere la propria preferenza riguardo 16 coppie di trattamenti che gli 
vengono prospettati, e chiede il suo consiglio. 
Riporti il suo consiglio ad Antonio riguardo ogni coppia di trattamenti A e B ponendo una X 
nel riquadro sotto di esse. 
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T1 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 20 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 15 anni  
 Rischio infettivo: Standard  Rischio infettivo: Standard  
 Rischio neoplastico: Aumentato  Rischio neoplastico: Standard  
 Elevata probabilità di attendere in lista 
per: 6 mesi  
Elevata probabilità di attendere in lista per: 
6 mesi  
 ☐  ☐  
   
T2 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 15 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 20 anni  
 Rischio infettivo: Standard  Rischio infettivo: Aumentato  
 Rischio neoplastico: Standard  Rischio neoplastico: Aumentato  
 Elevata probabilità di attendere in lista 
per: 12 mesi  
Elevata probabilità di attendere in lista per: 
36 mesi  
 ☐  ☐  
   
T3 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 20 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 15 anni  
 Rischio infettivo: Standard  Rischio infettivo: Aumentato  
 Rischio neoplastico: Aumentato  Rischio neoplastico: Standard  
 Elevata probabilità di attendere in lista 
per: 60 mesi  
Elevata probabilità di attendere in lista per: 
6 mesi  
 ☐  ☐  
   
T4 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 10 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 10 anni  
 Rischio infettivo: Aumentato  Rischio infettivo: Standard  
 Rischio neoplastico: Aumentato  Rischio neoplastico: Aumentato  
 Elevata probabilità di attendere in lista 
per: 6 mesi  
Elevata probabilità di attendere in lista per: 
12 mesi  
 ☐  ☐  
   
T5 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 10 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 10 anni  
 Rischio infettivo: Aumentato  Rischio infettivo: Standard  
 Rischio neoplastico: Standard  Rischio neoplastico: Standard  
 Elevata probabilità di attendere in lista 
per: 36 mesi  
Elevata probabilità di attendere in lista per: 
60 mesi  
 ☐   ☐  
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T6 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 15 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 10 anni  
 Rischio infettivo: Aumentato  Rischio infettivo: Aumentato  
 Rischio neoplastico: Aumentato  Rischio neoplastico: Standard  
 Elevata probabilità di attendere in lista 
per: 60 mesi  
Elevata probabilità di attendere in lista per: 
36 mesi  
 ☐  ☐  
   
T7 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 20 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 20 anni  
 Rischio infettivo: Aumentato  Rischio infettivo: Standard  
 Rischio neoplastico: Standard  Rischio neoplastico: Aumentato  
 Elevata probabilità di attendere in lista 
per: 60 mesi  
Elevata probabilità di attendere in lista per: 
60 mesi  
 ☐  ☐  
   
T8 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 15 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 10 anni  
 Rischio infettivo: Standard  Rischio infettivo: Aumentato  
 Rischio neoplastico: Aumentato  Rischio neoplastico: Aumentato  
 Elevata probabilità di attendere in lista 
per: 36 mesi  
Elevata probabilità di attendere in lista per: 
6 mesi  
 ☐  ☐  
   
T9 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 15 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 20 anni  
 Rischio infettivo: Standard  Rischio infettivo: Aumentato  
 Rischio neoplastico: Standard  Rischio neoplastico: Standard  
 Elevata probabilità di attendere in lista 
per: 6 mesi  
Elevata probabilità di attendere in lista per: 
12 mesi  
 ☐  ☐  
   
T10 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 10 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 15 anni  
 Rischio infettivo: Standard  Rischio infettivo: Aumentato  
 Rischio neoplastico: Aumentato  Rischio neoplastico: Aumentato  
 Elevata probabilità di attendere in lista 
per: 12 mesi  
Elevata probabilità di attendere in lista per: 
60 mesi  
 ☐  ☐  
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T11 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 20 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 20 anni  
 Rischio infettivo: Aumentato  Rischio infettivo: Standard  
 Rischio neoplastico: Standard  Rischio neoplastico: Standard  
 Elevata probabilità di attendere in lista 
per: 12 mesi  
Elevata probabilità di attendere in lista per: 
36 mesi  
 ☐  ☐  
 
T12 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 15 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 15 anni  
 Rischio infettivo: Aumentato Rischio infettivo: Standard 
 Rischio neoplastico: Standard  Rischio neoplastico: Standard 
 Elevata probabilità di attendere in lista 
per: 6 mesi  
Elevata probabilità di attendere in lista 
per: 12 mesi  
 ☐  ☐  
   
T13 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 10 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 15 anni  
 Rischio infettivo: Standard  Rischio infettivo: Aumentato  
 Rischio neoplastico: Standard  Rischio neoplastico: Aumentato  
 Elevata probabilità di attendere in lista 
per: 60 mesi  
Elevata probabilità di attendere in lista 
per: 12 mesi  
 ☐  ☐  
   
T14 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 20 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 20 anni  
 Rischio infettivo: Aumentato  Rischio infettivo: Aumentato  
 Rischio neoplastico: Aumentato  Rischio neoplastico: Standard  
 Elevata probabilità di attendere in lista 
per: 36 mesi  
Elevata probabilità di attendere in lista 
per: 60 mesi  
 ☐  ☐  
   
T15 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 20 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 20 anni  
 Rischio infettivo: Standard  Rischio infettivo: Standard  
 Rischio neoplastico: Standard  Rischio neoplastico: Aumentato  
 Elevata probabilità di attendere in lista 
per: 36 mesi  
Elevata probabilità di attendere in lista 
per: 6 mesi  
 ☐  ☐  
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T16 Trattamento A  Trattamento B  
 Elevata probabilità che l'organo 
trapiantato sia funzionante per: 15 anni  
Elevata probabilità che l'organo trapiantato 
sia funzionante per: 15 anni  
 Rischio infettivo: Aumentato  Rischio infettivo: Standard  
 Rischio neoplastico: Aumentato  Rischio neoplastico: Aumentato  
 Elevata probabilità di attendere in lista 
per: 12 mesi  
Elevata probabilità di attendere in lista 
per: 36 mesi  
 ☐  ☐  
 
 
Abilità logiche  
Ora vorrei farle alcune domande che servono per valutare come le persone usino i numeri 
nella vita di tutti i giorni.  
 
A1) La probabilità di contrarre una malattia è pari al 10 percento. Su 1000 persone, quante ci 
si può aspettare che si ammalino?  
………………………….  
A2) Durante i saldi, un negozio vende tutto a metà prezzo. Prima dei saldi, un divano costava 
300 euro; quanto costerà lo stesso divano durante i saldi?  
…………………………. 
A3) Un rivenditore di auto usate vende un’auto a 6.000 Euro, pari ai due terzi (2/3) del costo 
della stessa auto nuova. Quanto costava l’auto nuova?  
………………………….  
 
 
 
Il questionario è terminato. La ringraziamo per la sua preziosa collaborazione.  
Le ricordo che questo questionario ha soli scopi scientifici e non ha alcuna rilevanza per 
quanto riguarda il tipo di terapia che le verrà proposta o le scelte future che eventualmente Lei 
sarà chiamato a fare in accordo con la équipe di medici che La segue. 
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